{
  "meta": {
    "title": "00461_Late_Night_Pyq_Inicet_Medicine-2",
    "url": "https://brainandscalpel.vercel.app/00461-late-night-pyq-inicet-medicine-2-d47fdc40.html",
    "scrapedAt": "2025-11-29T18:11:17.974Z"
  },
  "questions": [
    {
      "id": 11636,
      "choices": [
        {
          "id": 46510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Klebsiella pneumoniae</span></span></span></p>"
        },
        {
          "id": 46511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Streptococcus pneumoniae</span></span></span></p>"
        },
        {
          "id": 46512,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mycoplasma pneumoniae</span></span></span></p>"
        },
        {
          "id": 46513,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Staphylococcus pneumoniae</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30 month old male child was brought with history of fever, and respiratory distress. Suspecting pneumonia , a chest xray was ordered. Which of the following is the most likely causative agent ? (AIIMS NOV 2017)</span></span></p>",
      "unique_key": "Q1079937",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066774,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Staphylococcus pneumoniae</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chest xray of child shows air filled cysts within lung parenchyma which are also known as pneumatoceles, and these are caused by staphylococcus pneumoniae.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Staphylococcus pneumoniae can cause primary or secondary pneumoniae (eg post influenza)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features &ndash; dyspnea, tachycardia, high fever, abdominal pain. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Staphylococcus aureus is also associated with complications like early development of empyema , pneumatocele , pyopneumothorax and bronchopleural fistula. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Klebsiella pneumoniae:</span></strong><span style=\"font-size:12.0pt\"> While this organism can cause pneumonia, it is more commonly associated with pneumonia in adults with a characteristic &quot;currant jelly&quot; sputum and does not typically lead to pneumatocele formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Streptococcus pneumoniae:</span></strong><span style=\"font-size:12.0pt\"> This is a common cause of bacterial pneumonia but typically does not cause pneumatoceles. It usually presents with lobar consolidation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mycoplasma pneumoniae:</span></strong><span style=\"font-size:12.0pt\"> Often causes atypical pneumonia in older children and young adults, characterized by a more gradual onset of symptoms and a less severe clinical picture compared to bacterial pneumonia. Pneumatoceles are not a common feature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Staphylococcus aureus can cause severe pneumonia in children, often complicated by the formation of pneumatoceles and other serious complications such as empyema and bronchopleural fistula.</span></span></span></p>",
      "correct_choice_id": 46513,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11505,
      "choices": [
        {
          "id": 45986,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroids</span></p>"
        },
        {
          "id": 45987,
          "text": "<p><span style=\"font-size:12.0pt;\">IVIG</span></p>"
        },
        {
          "id": 45988,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmapheresis</span></p>"
        },
        {
          "id": 45989,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventilator support</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a treatment option in Guillain Barre syndrome? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q3097940",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066771,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Steroids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Steroids are not effective in the treatment of Guillain-Barre Syndrome (GBS) and do not improve outcomes. This has been confirmed by multiple studies and clinical trials, leading to their non-recommendation in GBS management protocols.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While steroids have no role in acute GBS treatment, they are used in managing Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), which is a related condition that requires long-term immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IVIG (Intravenous Immunoglobulin):&nbsp;</strong>IVIG is a widely accepted treatment for GBS, where it is used to modulate the immune response. The typical regimen involves a total dose of 2 g/kg given over 2-5 days. IVIG is believed to neutralize circulating antibodies and reduce inflammation, leading to a decrease in the severity and duration of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Plasmapheresis:&nbsp;</strong>Also known as plasma exchange, plasmapheresis is used in GBS to remove harmful antibodies from the blood. This treatment is particularly useful in severe cases and is often started within the first two weeks of symptom onset for maximum effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ventilator support:&nbsp;</strong>Because GBS can lead to paralysis of the muscles used for breathing, ventilator support may be necessary for patients with severe respiratory muscle weakness. This supportive care is crucial in managing life-threatening complications of GBS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Steroids are not recommended for treating Guillain-Barre Syndrome due to their lack of efficacy in this specific condition, while IVIG and plasmapheresis are effective treatments. Supportive care, such as ventilator support, plays a vital role in managing severe cases where respiratory muscles are compromised.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison neurology, Immune mediated neuropathies/GBS/Chap 447/12730</strong></span></p>",
      "correct_choice_id": 45986,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11486,
      "choices": [
        {
          "id": 45910,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic encephalopathy</span></p>"
        },
        {
          "id": 45911,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized tonic clonic seizures</span></p>"
        },
        {
          "id": 45912,
          "text": "<p><span style=\"font-size:12.0pt;\">Creutzfeldt-Jakob Disease</span></p>"
        },
        {
          "id": 45913,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes simplex encephalitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">EEG pattern given below is suggestive of which of the following diseases? (AIIMS MAY 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm74.jpg\" alt=\"\" width=\"300\" height=\"194\"></span></p>",
      "unique_key": "Q6068114",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066762,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Creutzfeldt- Jakob Disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Periodic sharp wave complexes occurring every 1 second is usually seen in sporadic CJD.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Spongiform encephalopathy characterized by rapidly progressive dementia, myoclonus, akinetic mutism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">**Startle myoclonus is very peculiar feature observed in CJD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Signs on MRI:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Sporadic CJD:&nbsp;</strong>80-90% - Cortical-Ribbon sign on MRI.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Variant CJD:&nbsp;</strong>Hockey-stick appearance on MRI.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Metabolic encephalopathies show <strong>triphasic wave</strong> (Negative-positive-negative waves).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>GTCS shows high voltage, spike wave discharges in all leads.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>HSV show periodic lateralized epileptiform discharge (PLED) arising from temporal lobes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Creutzfeldt-Jakob Disease is associated with distinct EEG findings that are crucial for its diagnosis. Understanding the typical EEG patterns along with clinical presentation and advanced imaging can aid in the early and accurate diagnosis of this rapidly progressive and fatal disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21e/Neurology/Dementia/chap 438/12420</strong></span></p>",
      "correct_choice_id": 45912,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11439,
      "choices": [
        {
          "id": 45722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infective cardiomyopathy</span></span></span></span></p>"
        },
        {
          "id": 45723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takotsubo cardiomyopathy</span></span></span></span></p>"
        },
        {
          "id": 45724,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myocardial infarction</span></span></span></span></p>"
        },
        {
          "id": 45725,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophic cardiomyopathy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">60-year-old lady presented with chest pain and exertional dyspnea. Her family says she was previously healthy and there was no similar disease in the family members. ECG on arrival is suggestive of Anterior wall MI. Her son succumbed to Severe COVID-19 pneumonia. CAG showed normal epicardial coronaries. What is the likely diagnosis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q6407474",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066730,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Takotsubo cardiomyopathy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress cardiomyopathy <strong>commonly affects Women (post-menopausal) &gt; men predominantly</strong> due to emotional &gt; physical stress.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurogenic myocardial stunning</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>occurs leading to heart failure</strong>. Beta2 (Gs stimulation) at base and Beta2 (Gi) activation leads to hypercontractility at the base &amp; <em>apical ballooning</em> giving a typical <strong><em>Takotsubo appearance</em></strong><em>.</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ECG mimic ACS</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, RWMA not corresponding to single artery territory, normal CAG with <em>Mild troponin elevation are clues to takotsubo.</em></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T<strong>reatment with beta-blockers, ACE inhibitors if non-responsive</strong>. Carries good prognosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No signs of infection/Inflammation are given in the history. In presence of stress and temporal association, infection less likely.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal CAG rules out significant macrovascular CAD.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HCM shows dagger like q waves</strong>, SAM, Asymmetrical septal hypertrophy on ECHO.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takotsubo cardiomyopathy can present with symptoms and ECG changes similar to those of an acute myocardial infarction, but it is distinguished by normal coronary arteries on angiography and is often precipitated by severe emotional stress, fitting the patient&#39;s recent personal history.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Cardiology/Cardiomyopathies/Chap 259. </span></span></strong></span></span></p>",
      "correct_choice_id": 45723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11649,
      "choices": [
        {
          "id": 46562,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">FAMMM Syndrome</span></p>"
        },
        {
          "id": 46563,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">FAP</span></p>"
        },
        {
          "id": 46564,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hereditary pancreatitis</span></p>"
        },
        {
          "id": 46565,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Peutz Jegher’s syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pancreatic cancer has the highest association with:&nbsp;</span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p>",
      "unique_key": "Q1927010",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066709,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Peutz Jegher’s syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peutz-Jeghers syndrome (PJS) is significantly associated with an increased risk of pancreatic cancer. PJS is an autosomal dominant disorder characterized by the development of benign polyps in the gastrointestinal tract and distinctive pigmented spots on the skin. It is caused by mutations in the STK11 (LKB1) gene. Individuals with PJS have a markedly increased risk of developing several types of cancer, including a 36% lifetime risk of developing pancreatic cancer, which is considerably higher compared to the general population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. FAMMM Syndrome:</strong> While FAMMM (familial atypical multiple mole melanoma) syndrome, associated with mutations in the p16/CDKN2A gene, increases the risk for melanoma and pancreatic cancer, its association with pancreatic cancer is not as strong as that seen in PJS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. FAP (Familial Adenomatous Polyposis):</strong> FAP, primarily known for its high risk of colorectal cancer, also has some association with other cancers including pancreatic cancer, but again not as high as PJS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hereditary pancreatitis:</strong> Typically caused by mutations in the PRSS1 gene, hereditary pancreatitis does increase the risk for pancreatic cancer, but the risk is less compared to PJS.</span></p><p><br><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Pancreatic cancer has highest association with Peutz Jeghers syndrome.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Hereditary risk factors -</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Peutz Jeghers syndrome- STK 11 (LKB1)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hereditary pancreatitis – PRSS1 / SPIN 11</span></li><li><span style=\"color:black;font-size:12.0pt;\">Cystic fibrosis – CFTR</span></li><li><span style=\"color:black;font-size:12.0pt;\">FAMMM (familial atypical multiple mole melanoma)- p16/ CDKN2A</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hereditary breast &amp;ovarian cancer- BRCA2</span></li><li><span style=\"color:black;font-size:12.0pt;\">HNPCC/ Lynch syndrome – MLH1, MSH2, MSH 6, PMS2</span></li></ul>",
      "correct_choice_id": 46565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11453,
      "choices": [
        {
          "id": 45778,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leflunomide</span></span></span></span></p>"
        },
        {
          "id": 45779,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Febuxostat</span></span></span></span></p>"
        },
        {
          "id": 45780,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate</span></span></span></span></p>"
        },
        {
          "id": 45781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Etanercept</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs is not used in rheumatoid arthritis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q8571964",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066739,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Febuxostat</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Febuxostat is not used in the treatment of rheumatoid arthritis. It is a xanthine oxidase inhibitor primarily used as a hypouricemic agent for managing gout by reducing uric acid production. Its primary function is to alleviate the symptoms and prevent the recurrence of gout, not to treat inflammatory or autoimmune conditions like rheumatoid arthritis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>A. Leflunomide:</strong> Incorrect choice for the given answer as Leflunomide is indeed used in the treatment of rheumatoid arthritis. It is a disease-modifying antirheumatic drug (DMARD) that works by suppressing the immune system to reduce inflammation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C. Methotrexate:</strong> Incorrect because Methotrexate is a cornerstone treatment for rheumatoid arthritis. It is another DMARD that helps reduce joint damage and decrease the pain and swelling associated with RA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D. Etanercept:</strong> Incorrect as it is also used in rheumatoid arthritis treatment. Etanercept is a TNF (tumor necrosis factor) inhibitor, which is a type of biologic therapy that helps to decrease inflammation and slow disease progression in RA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Febuxostat is specifically used to manage gout by lowering uric acid levels and does not have a role in the treatment regimen for rheumatoid arthritis, which typically involves DMARDs and biologic agents aimed at controlling systemic inflammation and preventing joint damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Rheumatology/RA/Chap 358</span></span></strong></span></span></p>",
      "correct_choice_id": 45779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11443,
      "choices": [
        {
          "id": 45738,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood pressure more than 130/85mmHg</span></p>"
        },
        {
          "id": 45739,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive sleep apnea</span></p>"
        },
        {
          "id": 45740,
          "text": "<p><span style=\"font-size:12.0pt;\">LDL more than 100 mg/dl</span></p>"
        },
        {
          "id": 45741,
          "text": "<p><span style=\"font-size:12.0pt;\">Fasting triglyceride &gt;150 mg/dl</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a component of Syndrome Z? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q8088458",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066733,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) LDL more than 100 mg/dl</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Syndrome Z also known as Metabolic Syndrome, is characterized by a cluster of conditions that increase the risk of heart disease, stroke, and diabetes. Syndrome involve the pressence of any three of the following five traits:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Any 3/5 for diagnosis:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Central Obesity:</strong> &gt; 102cm (M),&gt; 88 cm (F); [90(M), 80 cm (F) <i>in Indians</i>]: Only if questions specifically mention <i>Indian population.</i></span></li><li><span style=\"font-size:12.0pt;\">BP &gt; 130/85 mmHg</span></li><li><span style=\"font-size:12.0pt;\">FBS &gt; 100 mg/dL<s>/A1c</s></span></li><li><span style=\"font-size:12.0pt;\">Low HDL (in mg/dL): &lt; 40 (F), &lt; 50 <s>cm</s>(M)</span></li><li><span style=\"font-size:12.0pt;\">High TGL: &gt; 150 mg/dL</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While LDL cholesterol management is crucial in cardiovascular risk reduction, it is not one of the criteria for diagnosing Metabolic Syndrome, which focuses on abdominal obesity, blood pressure, fasting blood sugar, HDL cholesterol, and triglycerides.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Gastro/Fatty liver/Chap408</strong></span></p>",
      "correct_choice_id": 45740,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11459,
      "choices": [
        {
          "id": 45802,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid Arthritis</span></span></span></span></p>"
        },
        {
          "id": 45803,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osteoarthritis</span></span></span></span></p>"
        },
        {
          "id": 45804,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complex Regional Pain Syndrome</span></span></span></span></p>"
        },
        {
          "id": 45805,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Villonodular synovitis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly woman presents with a chronic history of pain in the small joints of hands with stiffness of joints in the early hours of the day. The image of the patient&#39;s hands is given below. What is the most likely diagnosis? (AIIMS MAY 2018)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm64.jpg\" style=\"height:314px; width:300px\" /></span></span></p>",
      "unique_key": "Q9502587",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066744,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Rheumatoid Arthritis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early diagnosis of RA is crucial. May present with mono/oligoarthritis. Inflammation (stiffness &gt; 30 mins) is significant.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RA +ve: 70%, anti-CCP+ve:75%. <em>Hence 1/5th SERONEGATIVE</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rule out Psoriatic arthritis, Crystal arthropathies, CTD, Hansens, Polymyalgia rheumatica before labeling seronegative RA</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Get baseline CBC, LFT, RFT, HbsAg, Anti-HCV</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start DMARD - Mtx 7.5-10 mg/week, gradually </span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&uarr; to</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 25 mg/wk. Avoid DMARDs cocktail.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OA usually morning stiffness &lt;15-30 mins. Bouchard, Heberden nodes in late stages.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complex regional pain syndrome (CRPS) is a condition that can develop after <strong>peripheral nerve injury</strong>, wherein patients experience unprovoked pain in the area supplied by the affected nerve. Sympathetic innervation to the affected area can be disrupted, and blocking this sympathetic activity with a local anesthetic can sometimes alleviate the pain. Notably, damaged nerve fibers become sensitive to adrenergic signals, allowing them to be activated by the sympathetic nervous system. This constellation of symptoms, including <strong>spontaneous pain and signs of disrupted sympathetic function</strong>, characterizes CRPS.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Villonodular Synovitis is&nbsp;</span></strong></span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">c</span>haracterized by joint swelling due to excess synovial growth and potential bleeding into the joint, leading to pain and restricted movement, which is less likely given the chronic symmetrical joint involvement typical of RA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid Arthritis is suggested by the presence of symmetrical small joint pain and stiffness, particularly in the morning, with potential visible joint deformities. Early and aggressive treatment is vital to manage symptoms and prevent progressive joint damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Rheumatology/RA/Chap&nbsp; </span></span></strong></span></span></p>",
      "correct_choice_id": 45802,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11450,
      "choices": [
        {
          "id": 45766,
          "text": "<p><span style=\"font-size:12.0pt;\">Clostridium</span></p>"
        },
        {
          "id": 45767,
          "text": "<p><span style=\"font-size:12.0pt;\">Klebsiella</span></p>"
        },
        {
          "id": 45768,
          "text": "<p><span style=\"font-size:12.0pt;\">Acinetobacter</span></p>"
        },
        {
          "id": 45769,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemophilus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely causative organism of ventilator-associated pneumonia among the following? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q3282459",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066737,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Acinetobacter.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acinetobacter species are particularly prevalent in hospital settings and are a common cause of ventilator-associated pneumonia (VAP). These organisms are known for their ability to survive on surfaces for extended periods and their resistance to multiple antibiotics, making them a significant concern in intensive care units where patients are often intubated. Acinetobacter, along with Pseudomonas and Stenotrophomonas, is known for colonizing the respiratory tract of ventilated patients, leading to VAP, which typically occurs after 48 hours of mechanical ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Clostridium:&nbsp;</strong>This genus, including species like Clostridium difficile, is more commonly associated with gastrointestinal infections, particularly antibiotic-associated diarrhea, rather than pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Klebsiella:&nbsp;</strong>While Klebsiella pneumoniae can cause ventilator-associated pneumonia, it is generally less common than Acinetobacter in this specific infection context. Klebsiella tends to be more associated with community-acquired pneumonia and hospital-acquired infections outside of the ventilator context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haemophilus:&nbsp;</strong>Haemophilus influenzae can cause respiratory tract infections but is more commonly linked to community-acquired pneumonia and exacerbations of chronic obstructive pulmonary disease rather than VAP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acinetobacter, pseudomonas, stenotrophomonas, Burkholderia cepacia are common organisms causing VAP. VAP occurs due to colonization by organisms in &lt; 48 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Pulmonology/Pneumonia/Chap 142</strong></span></p>",
      "correct_choice_id": 45768,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11413,
      "choices": [
        {
          "id": 45618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">AIDP with migraine </span></span></span></span></p>"
        },
        {
          "id": 45619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Right side paralysis</span></span></span></span></p>"
        },
        {
          "id": 45620,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Acute intermittent porphyria</span></span></span></span></p>"
        },
        {
          "id": 45621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Conversion disorder</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 22-year-old female patient came with complaints of vomiting and a decrease in movement of the right leg. In the past, she has had episodes of violent and aggressive behavior and abdominal pain. Which of the following is the most probable diagnosis? (AIIMS MAY 2017)</span></span></span></p>",
      "unique_key": "Q7108092",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066716,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Acute intermittent porphyria</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vomiting &amp; decreased movements of right leg in young female with previous history of abdominal pain and mental symptoms like violent and aggressive behavior points towards acute intermittent porphyria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute intermittent porphyria is an <strong>autosomal dominant disorder</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is due to <strong>deficiency of HMB Synthase enzyme</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ACUTE INTERMITTENT PORPHYRIA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Common precipitating factors include endogenous and exogeneous steroids, porphyrinogenic drugs, alcohol ingestion and low-calorie diets, usually instituted for weight loss.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Symptoms are <strong>more common in women</strong>, suggesting a role for estrogens or progestins.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abdominal pain, the most common symptom is usually steady and poorly localized but maybe cramping.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nausea, vomiting, constipation, tachycardia hypertension, mental symptoms, pain in the limbs, head, neck or chest, muscle weakness, sensory loss, dysuria, and urinary retention are characteristic. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>peripheral neuropathy is due to neurologic axonal degeneration</strong> (rather than demyelination) and primarily affects motor neurons.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mental symptoms</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> such as anxiety, insomnia, depression, disorientation, hallucination and paranoia can occur in acute attacks. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Seizures can be due to neurologic effects or to hyponatremia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (due to hypothalamic involvement and inappropriate vasopressin secretion or from electrolyte depletion due to vomiting, diarrhea, poor intake or excess renal sodium loss).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ALA &amp; PBG levels are substantially increased in plasma and urine, especially during acute attacks.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I.V. Hemin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is more effective and should be used as first line therapy for all acute attacks.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. AIDP with migraine:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because AIDP (Acute Inflammatory Demyelinating Polyneuropathy) presents with rapid onset muscle weakness and decreased reflexes, not specifically associated with vomiting or abdominal pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Right side paralysis:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as this diagnosis does not account for the broader spectrum of symptoms including behavioral changes and abdominal pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Conversion disorder:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because conversion disorder involves symptoms that suggest neurological or medical conditions but are actually manifestations of psychological conflict or needs. The specific clinical presentation and past medical history in this case strongly point towards a physiological rather than psychological cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The acute intermittent porphyria presents with a complex array of symptoms, including neurological, gastrointestinal, and psychiatric manifestations, and is associated with specific triggers and a genetic basis. Elevated ALA and PBG levels during attacks are diagnostic.</span></span></span></p>",
      "correct_choice_id": 45620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11416,
      "choices": [
        {
          "id": 45630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Subclinical hypothyroidism</span></span></span></span></p>"
        },
        {
          "id": 45631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperthyroidism</span></span></span></span></p>"
        },
        {
          "id": 45632,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Secondary hypothyroidism</span></span></span></span></p>"
        },
        {
          "id": 45633,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Primary hypothyroidism</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">On thyroid function test analysis, TSH value was much higher than normal with low free T4. What is the diagnosis? (AIIMS MAY 2017)</span></span></span></p>",
      "unique_key": "Q7003059",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066718,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Primary hypothyroidism</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HYPOTHYROIDISM</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Types:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary Hypothyroidism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Increased TSH with low T4 levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary hypothyroidism </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- TSH can be low, normal or elevated slightly. The latter is due to secretion of immune-active but bio-active forms of TSH. Confirmation of diagnosis is done by detecting low levels of unbound T4. </span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Evaluation of Hypothyroidism:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture30.jpg\" style=\"height:362px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Subclinical hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because subclinical hypothyroidism would show an elevated TSH but normal free T4 levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hyperthyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as hyperthyroidism would typically present with low TSH and high free T4 levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Secondary hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect for this scenario because secondary hypothyroidism involves a problem with pituitary TSH production, which does not typically result in a significantly elevated TSH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The primary hypothyroidism is characterized by high TSH and low free T4 levels, indicating a failure of the thyroid gland itself to produce sufficient hormones.</span></span></span></p>",
      "correct_choice_id": 45633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11503,
      "choices": [
        {
          "id": 45978,
          "text": "<p><span style=\"font-size:12.0pt;\">Flexor tenosynovitis</span></p>"
        },
        {
          "id": 45979,
          "text": "<p><span style=\"font-size:12.0pt;\">Dupuytrens contracture</span></p>"
        },
        {
          "id": 45980,
          "text": "<p><span style=\"font-size:12.0pt;\">Cheiroarthropathy</span></p>"
        },
        {
          "id": 45981,
          "text": "<p><span style=\"font-size:12.0pt;\">Ankyloses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A diabetic patient walks into your clinic and does \"namaste\". The image is given below. What could be the probable cause? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm78.jpg\" alt=\"\" width=\"300\" height=\"281\"></span></p>",
      "unique_key": "Q3819235",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066769,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Cheiroarthropathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Incomplete approximation of one or more of the digits when the patient attempts to approximate the palmar surfaces of the proximal and distal interphalangeal joints with palms pressed together and the fingers abducted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is associated with <strong>both Microvascular disease and macrovascular risk</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Flexor tenosynovitis:&nbsp;</strong>Involves inflammation of the tendon sheaths and is typically painful, which might include swelling and crepitus upon movement. It does not typically present with the inability to approximate the palms as in cheiroarthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dupuytren's contracture:&nbsp;</strong>Results in fibrosis of the palmar fascia leading to permanent bending of the fingers into the palm. Unlike cheiroarthropathy, Dupuytren's typically produces visible nodules and cords in the palm, pulling the fingers inward.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ankylosis:&nbsp;</strong>Involves the complete fusion of a joint leading to total immobility. This would manifest as rigid, immovable joints in fixed positions, not merely stiff and difficult to approximate as in cheiroarthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cheiroarthropathy is a significant indicator of chronic diabetic complications affecting the connective tissue. Recognizing this condition is important as it often correlates with other microvascular complications of diabetes such as retinopathy and nephropathy, prompting comprehensive management of the patient's diabetes to prevent further complications.</span></p>",
      "correct_choice_id": 45980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11506,
      "choices": [
        {
          "id": 45990,
          "text": "<p><span style=\"font-size:12.0pt;\">Retrolentiform</span></p>"
        },
        {
          "id": 45991,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior limb</span></p>"
        },
        {
          "id": 45992,
          "text": "<p><span style=\"font-size:12.0pt;\">Sublentiform</span></p>"
        },
        {
          "id": 45993,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior limb</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which part of the internal capsule is affected in hemiplegia due to ischemic stroke? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q9207152",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066772,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;Posterior Limb</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The posterior limb of the internal capsule is the most commonly affected area in cases of hemiplegia due to ischemic stroke. This area carries the corticospinal tract, which is essential for motor control. When the posterior limb is compromised, it disrupts the corticospinal pathway, leading to muscle weakness or paralysis on the opposite side of the body from the lesion.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture36.jpg\" alt=\"\" width=\"500\" height=\"425\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture37.jpg\" alt=\"\" width=\"1000\" height=\"723\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Retrolentiform:&nbsp;</strong>Primarily involved in visual processing. Damage here would likely lead to visual field defects rather than motor dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anterior limb:&nbsp;</strong>Primarily associated with cognitive and emotional functions due to its connectivity between the thalamus and the frontal lobe. Lesions here generally do not cause hemiplegia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sublentiform:&nbsp;</strong>Involved in auditory and gustatory pathways, thus unrelated to motor control functions affected in hemiplegia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of ischemic stroke, damage to the posterior limb of the internal capsule results in hemiplegia because of the disruption of corticospinal tracts. This knowledge aids in accurate stroke localization and informs rehabilitation strategies to help regain motor functions.</span></p>",
      "correct_choice_id": 45993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11481,
      "choices": [
        {
          "id": 45890,
          "text": "<p><span style=\"font-size:12.0pt;\">RA factor</span></p>"
        },
        {
          "id": 45891,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholesterol crystals</span></p>"
        },
        {
          "id": 45892,
          "text": "<p><span style=\"font-size:12.0pt;\">High glucose</span></p>"
        },
        {
          "id": 45893,
          "text": "<p><span style=\"font-size:12.0pt;\">High LDH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following characteristics are found in the pleural effusion fluid of a rheumatoid arthritis patient except: (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q7891424",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066757,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) High Glucose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rheumatoid pleural effusion, associated with rheumatoid arthritis, typically presents with low glucose levels, making high glucose the correct answer as it is not a characteristic found in such effusions. The low glucose in rheumatoid pleural effusion is due to increased metabolic activity of leukocytes and pleural cells which consume glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A. RA factor:&nbsp;</strong>The presence of RA factor (Rheumatoid factor) in pleural fluid is commonly seen in patients with rheumatoid arthritis. Rheumatoid factor is an autoantibody found in the blood of approximately 80% of adults with rheumatoid arthritis. Its presence in pleural fluid reflects the systemic inflammatory nature of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Cholesterol crystals:&nbsp;</strong>Cholesterol crystals in the pleural fluid are indicative of a long-standing effusion, which can occur in chronic rheumatoid pleuritis. These crystals form as the pleural fluid becomes more concentrated over time due to the chronic nature of the inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. High LDH:&nbsp;</strong>High levels of lactate dehydrogenase (LDH) in the pleural fluid are a common feature of exudative effusions, including those caused by rheumatoid arthritis. LDH is an enzyme present in most cells and is released into the pleural fluid when cells are damaged or destroyed, reflecting the inflammatory processes occurring in rheumatoid pleuritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture47.jpg\" alt=\"\" width=\"500\" height=\"607\"></span></p>",
      "correct_choice_id": 45892,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11475,
      "choices": [
        {
          "id": 45866,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluctuating cognition</span></p>"
        },
        {
          "id": 45867,
          "text": "<p><span style=\"font-size:12.0pt;\">REM sleep behavior disorder</span></p>"
        },
        {
          "id": 45868,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent visual hallucinations</span></p>"
        },
        {
          "id": 45869,
          "text": "<p><span style=\"font-size:12.0pt;\">Orthostatic hypotension</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All of the following are the core clinical features for the diagnosis of Lewy body dementia except:</span></p>",
      "unique_key": "Q9231937",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066753,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Orthostatic hypotension.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lewy body dementia (LBD), also known as dementia with Lewy bodies, is characterized by specific core clinical features. Orthostatic hypotension, while commonly observed in LBD due to autonomic dysfunction, is not classified as a core clinical feature but rather as a supportive feature for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Central feature:&nbsp;</strong>Dementia (Essential for the diagnosis of DLB).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Core Clinical criteria include the following:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Fluctuating cognition with pronounced variations in attention and alertness.</span></li><li><span style=\"font-size:12.0pt;\">Recurrent visual hallucinations that are typically well formed and detailed.</span></li><li><span style=\"font-size:12.0pt;\">Rapid eye movement (REM) sleep behavior disorder (RBD).</span></li><li><span style=\"font-size:12.0pt;\">Spontaneous cardinal features of parkinsonism.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Supportive Features of LBD:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Autonomic Dysfunction:&nbsp;</strong>Including orthostatic hypotension.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Severe Sensitivity to Antipsychotic Drugs:&nbsp;</strong>Patients may experience severe motor and neuroleptic sensitivity.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Other Hallucinations and Neurological Signs:&nbsp;</strong>Can include auditory hallucinations or transient, unexplained loss of consciousness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Onset of dementia preceding or</strong> <strong>within 1 year&nbsp;</strong>of onset of parkinsonism differentiates Lewy Body dementia from Parkinson's disease with dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fluctuating cognition:&nbsp;</strong>Fluctuating cognition is one of the hallmark symptoms of LBD, characterized by significant variations in attention and alertness. This fluctuation is more pronounced than what is typically seen in other forms of dementia, such as Alzheimer's disease, and can vary from hour to hour or day to day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. REM sleep behavior disorder:&nbsp;</strong>REM sleep behavior disorder (RBD) is a core feature of LBD, where patients physically act out their dreams, often vividly. This disorder is a result of the loss of normal muscle atonia that should occur during REM sleep, leading to potentially violent movements and vocalizations during sleep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Recurrent visual hallucinations:&nbsp;</strong>Visual hallucinations in LBD are typically well-formed and detailed, often involving people or animals. These hallucinations are a core feature and differ from the more nebulous or less structured hallucinations seen in other disorders. They are thought to be due to the underlying Lewy body pathology affecting cortical brain areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Orthostatic hypotension is a supportive, not core, criterion for the diagnosis of Lewy body dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21e/Neurology, DLB Chapter 434 /12305.</strong></span></p>",
      "correct_choice_id": 45869,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11424,
      "choices": [
        {
          "id": 45662,
          "text": "<p style=\"margin-left:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Aspirin &amp; clopidogrel</span></span></span></span></p>"
        },
        {
          "id": 45663,
          "text": "<p style=\"margin-left:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Mannitol</span></span></span></span></p>"
        },
        {
          "id": 45664,
          "text": "<p style=\"margin-left:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Decompressive surgery </span></span></span></span></p>"
        },
        {
          "id": 45665,
          "text": "<p style=\"margin-left:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Mechanical thrombectomy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">A 53-year-old man was admitted with history of a cerebrovascular accident 2 days ago. The patient is drowsy with minimal response. CT findings is shown in the image below. What will be your next line of management? (AIIMS MAY 2017)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm59.jpg\" style=\"height:299px; width:250px\" /></span></span></span></span></p>",
      "unique_key": "Q6086774",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066722,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Decompressive surgery</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The CT scan image shows significant edema and midline shift affecting more than 50% of the Middle Cerebral Artery (MCA) territory. This extensive edema, along with the patient&#39;s low Glasgow Coma Scale (GCS) score, indicates severe brain swelling and increased intracranial pressure (ICP). In such cases, medical management alone (like mannitol for reducing ICP) may not be sufficient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Guidelines for urgent decompression: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">NIH Stroke scale &gt; 15</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Time &lt; 48 hours</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Age 18-60yrs</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Territory infarct &gt; 145cm<sup>3</sup><sup> </sup>or &gt; 50% MCA territory </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Informed consent that surgery improves survival but the patient may have significant disability. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medical management of brain edema and increased intracranial pressure (ICP) may not be successful when significant swelling occurs in the cerebral or cerebellar hemisphere. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, a decompressive craniectomy should be considered to relieve the mass effect of the swollen cerebral or cerebellar hemisphere on the thalamus, brainstem and network projections to the cortex, which is manifested predominantly by decreased levels of arousal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aspirin &amp; clopidogrel:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as these medications are used for preventing further thrombotic events but are not suitable in the acute management of severe edema and brain shift.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Mannitol:</span></strong><span style=\"font-size:12.0pt\"> Incorrect for sole use in this severe case, as it might not adequately control the mass effect and high ICP shown.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Mechanical thrombectomy:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because the primary issue in the CT image is the significant brain swelling and herniation risk, not an occlusion that can be resolved by thrombectomy at this stage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The cases of significant cerebral edema with midline shift, as seen on CT in acute stroke settings, decompressive surgery is often necessary to prevent fatal outcomes and manage increased intracranial pressure effectively.</span></span></span></p>",
      "correct_choice_id": 45664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11433,
      "choices": [
        {
          "id": 45698,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytarabine</span></span></span></span></p>"
        },
        {
          "id": 45699,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></span></span></span></p>"
        },
        {
          "id": 45700,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxorubicin</span></span></span></span></p>"
        },
        {
          "id": 45701,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old girl with the diagnosis of acute promyelocytic leukemia was treated medically. She developed fever and tachypnea and a chest X-ray showed pulmonary infiltrates. What drug should she be given next? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q9908169",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066727,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Dexamethasone</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct choice is B, Dexamethasone, because the symptoms described (fever, tachypnea, and pulmonary infiltrates) suggest the patient may be experiencing differentiation syndrome, which can occur following the treatment of acute promyelocytic leukemia (APML) with agents like Arsenic trioxide and All-Trans retinoic acid. Differentiation syndrome is characterized by such symptoms and can improve with the administration of Dexamethasone. Dexamethasone is also used intrathecally in children for treating Acute Myeloid Leukemia (AML), indicating its relevance in managing severe inflammatory reactions in hematological conditions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cytarabine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is incorrect as Cytarabine is primarily used in the treatment of acute myeloid leukemia and not specifically indicated for the management of differentiation syndrome in APML.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Doxorubicin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect because Doxorubicin is utilized for its efficacy against various cancers including Hodgkin&#39;s disease, cancer of the breast, and thyroid but is not suitable for treating differentiation syndrome in APML. It is also known for its cardiotoxic effects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Methotrexate:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect as it is not recommended in the treatment regimen for APML and does not address the immediate complications of differentiation syndrome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone is used to manage differentiation syndrome in patients with acute promyelocytic leukemia, characterized by symptoms like fever, tachypnea, and pulmonary infiltrates following treatment with specific leukemia drugs</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Oncology/Acute leukemia/chap100-743</span></span></strong></span></span></p>",
      "correct_choice_id": 45699,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11498,
      "choices": [
        {
          "id": 45958,
          "text": "<p><span style=\"font-size:12.0pt;\">Urgent consultation for dialysis</span></p>"
        },
        {
          "id": 45959,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone + fluids</span></p>"
        },
        {
          "id": 45960,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone + lenalidomide</span></p>"
        },
        {
          "id": 45961,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow transplantation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 65-year-old lady presented to the casualty with Hb - 5.4 g/dL, urea-86 mg/dL, creatinine- 6 mg/dL, calcium - 12 mg/dL, potassium - 4.4 mEq/L. Bone marrow aspiration shows &gt; 60% of plasma cells. What is the next line of management? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q9057740",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066767,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Dexamethasone + Fluids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Features are suggestive of M<strong>ultiple myeloma presenting with Mild Hypercalcemia with no pulmonary edema</strong>. Hence, treatment with steroids and IV fluids are recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Dialysis is recommended if Hyperkalemia, Pulmonary edema, refractory acidosis, and Uremia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>Dexamethasone + lenalidomide is recommended in definitive therapy for MM along with bortezomib +/- Daratumumab (Anti CD38).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Bone marrow transplant is considered upfront in high-risk disease as definitive therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immediate management of a newly diagnosed multiple myeloma patient presenting with anemia, renal failure, and hypercalcemia should prioritize rapid medical intervention to stabilize the patient. This includes hydration and the use of steroids to reduce plasma cell proliferation and calcium levels. Subsequent treatments will be based on the patient’s response and overall treatment strategy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Plasma cell dyscrasia/Chap 111</strong></span></p>",
      "correct_choice_id": 45959,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11437,
      "choices": [
        {
          "id": 45714,
          "text": "<p><span style=\"font-size:12.0pt;\">E2VTM3</span></p>"
        },
        {
          "id": 45715,
          "text": "<p><span style=\"font-size:12.0pt;\">E2VTM4</span></p>"
        },
        {
          "id": 45716,
          "text": "<p><span style=\"font-size:12.0pt;\">E2V1M3</span></p>"
        },
        {
          "id": 45717,
          "text": "<p><span style=\"font-size:12.0pt;\">E2VNTM3</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Calculate the GCS Score in an intubated patient, with findings of eye movements to pain and abnormal flexion? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q6639751",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066729,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) E2VNTM3</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Glasgow Coma Scale (GCS) score is used to assess the level of consciousness in patients with traumatic brain injury and other conditions. In this scenario, the patient is intubated, which affects the ability to assess the verbal response. The current nomenclature for denoting non-testability due to intubation is \"NT\" (Non-testable) for the verbal component.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Eye Opening (E):&nbsp;</strong>The patient opens eyes in response to painful stimuli, which scores 2.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Verbal Response (V):&nbsp;</strong>The verbal component is non-testable (NT) due to intubation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Motor Response (M):&nbsp;</strong>The patient exhibits abnormal flexion (decorticate response), which scores 3.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This combination gives a GCS score of E2VNTM3.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture50_HnLdYbm.jpg\" alt=\"\" width=\"1000\" height=\"326\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NT = non-testability of the corresponding component.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Used mainly in <strong>acute TBI&nbsp;</strong>(Traumatic brain injury).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Update:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. GCS-P Score&nbsp;</strong>takes pupillary activity into consideration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>P = </strong>Pupillary non-reactivity</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2 = </strong>Both pupil</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1 = </strong>One pupil</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>0 = </strong>None</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Minimum = 1, Max = 15.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. FOUR score&nbsp;</strong>(Full outline of unresponsiveness) is currently employed having better sensitivity, specificity and PPV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In intubated patients, the GCS verbal score is marked as \"NT\" for non-testable. The GCS remains a vital tool in assessing the level of consciousness, particularly in emergency and critical care settings, ensuring that changes in the patient’s neurological status are promptly recognized and appropriately managed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Neurology/Basics /Chapter 443-TBI</strong></span></p>",
      "correct_choice_id": 45717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11519,
      "choices": [
        {
          "id": 46042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 160/90 mmHg with one anti-hypertensive</span></span></span></span></p>"
        },
        {
          "id": 46043,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with one anti-hypertensive</span></span></span></span></p>"
        },
        {
          "id": 46044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with three or more anti hypertensives</span></span></span></span></p>"
        },
        {
          "id": 46045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 160/90 mmHg with three or more anti hypertensives</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension is defined as? (AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q5665159",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066783,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with three or more anti hypertensives.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension is defined as blood pressure that remains above goal despite the concurrent use of three anti-hypertensive agents of different classes. Typically, one of the three medications should be a diuretic, and all agents should be prescribed at optimal dose amounts. The threshold set for defining resistant hypertension is blood pressure greater than 140/90 mmHg.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension indicates a situation where blood pressure control is inadequate despite the use of multiple medications, which can pose significant risks for cardiovascular complications and requires careful evaluation for secondary causes. This includes assessing for white-coat HTN/Pseudo HTN, medication adherence, lifestyle factors, and secondary causes of hypertension like renal artery stenosis, endocrine disorders, or medication-induced hypertension.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Home BP monitoring, ABPM (Ambulatory BP monitoring) can help in optimization of drugs.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant HTN refers to BP &gt; 140/90 mmHg despite three anti-HTN, <em>one being a diuretic.</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21E/Cardiology/Hypertensive Disease/ chap 277&nbsp;&nbsp;&nbsp; </span></span></strong></span></span></p>",
      "correct_choice_id": 46044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11650,
      "choices": [
        {
          "id": 46566,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Endobronchial neoplasm </span></span></span></span></p>"
        },
        {
          "id": 46567,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Bronchial asthma</span></span></span></span></p>"
        },
        {
          "id": 46568,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Myasthenia gravis</span></span></span></span></p>"
        },
        {
          "id": 46569,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Emphysema</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The flow volume curve after spirometry in patient 1 is given below. The most likely diagnosis in this patient is?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (AIIMS NOV 2017)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm109.jpg\" style=\"height:314px; width:500px\" /></span></span></span></span></p>",
      "unique_key": "Q1743781",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066710,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C) Myasthenia gravis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">In patient 1, flow volume curve shows restrictive pattern, and it corresponds to myasthenia gravis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The flow volume curve shown indicates a restrictive pattern, which is characterized by reduced lung volumes but relatively preserved flow rates, consistent with non-obstructive lung pathology. Myasthenia gravis, a neuromuscular disorder, often affects the respiratory muscles leading to a restrictive ventilatory defect as depicted in the flow volume loop. This condition results from antibodies that block or destroy nicotinic acetylcholine receptors at the junction between the nerve and muscle, leading to muscle weakness including the respiratory muscles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Endobronchial neoplasm:</span></strong><span style=\"font-size:12.0pt\"> Typically presents with an obstructive pattern on spirometry due to airway obstruction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Bronchial asthma:</span></strong><span style=\"font-size:12.0pt\"> Asthma would show an obstructive pattern characterized by decreased peak expiratory flow and difficulty exhaling, which is not observed in the given curve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Emphysema:</span></strong><span style=\"font-size:12.0pt\"> Emphysema, part of chronic obstructive pulmonary diseases (COPD), would also exhibit an obstructive pattern with a &quot;scooped out&quot; appearance on the expiratory curve due to air trapping and reduced elastic recoil, which is not seen in the curve provided.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia gravis can present with a restrictive pattern on pulmonary function tests due to respiratory muscle weakness, differentiating it from conditions that cause obstructive patterns such as asthma and emphysema.</span></span></span></p>",
      "correct_choice_id": 46568,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11445,
      "choices": [
        {
          "id": 45746,
          "text": "<p><span style=\"font-size:12.0pt;\">Pott's Spine</span></p>"
        },
        {
          "id": 45747,
          "text": "<p><span style=\"font-size:12.0pt;\">Guillain Barre Syndrome</span></p>"
        },
        {
          "id": 45748,
          "text": "<p><span style=\"font-size:12.0pt;\">Cauda Equina Syndrome</span></p>"
        },
        {
          "id": 45749,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple Sclerosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient with a history of a backache for 10 days, has now presented with difficulty in micturition and defecation. There was no history of a cough or fever previously. What is the diagnosis? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q5906544",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066734,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Cauda-Equina syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Spinal cord ends at L1.&nbsp;</strong>Hence to accommodate the mismatch between vertebra and cord, the conus is formed from T12-L2 vertebral level housing the sacral portion of the cord. The lumbosacral roots descend downwards from conus and exit the corresponding foramina.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sacral (S2,3,4) are responsible for sensations of the bladder wall. Hence injury leads to absent sensation and bladder distension with dribbling of urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong>&nbsp;<strong>A. Pott's Spine:</strong> Incorrect because Pott's disease (tuberculosis of the spine) typically presents with chronic back pain associated with systemic symptoms like fever, night sweats, and weight loss due to the infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Guillain Barre Syndrome:</strong> Guillain Barre Syndrome primarily presents with ascending paralysis starting from the feet upwards, and sphincter involvement is rare, especially as an initial symptom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Multiple Sclerosis:</strong> Incorrect because Multiple Sclerosis involves demyelination primarily affecting the brain and spinal cord but typically causes chronic, rather than acute, symptoms, and would not likely present with acute bladder and bowel dysfunction without other neurological signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cauda Equina Syndrome presents with acute lower back pain and severe disturbances in bladder and bowel control due to compression of the nerve roots in the lumbar and sacral areas, requiring urgent medical attention to prevent permanent damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Neurology/Diseases of spinal Cord/Chap 442</strong></span></p>",
      "correct_choice_id": 45748,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11495,
      "choices": [
        {
          "id": 45946,
          "text": "<p><span style=\"font-size:12.0pt;\">Suction</span></p>"
        },
        {
          "id": 45947,
          "text": "<p><span style=\"font-size:12.0pt;\">Start antibiotics and send samples for culture</span></p>"
        },
        {
          "id": 45948,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest physiotherapy</span></p>"
        },
        {
          "id": 45949,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasound guided aspiration</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient who is intubated had an X-ray done. The radiograph is shown below. What is the next step in the management of this patient? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm75.jpg\" alt=\"\" width=\"300\" height=\"251\"></span></p>",
      "unique_key": "Q6034469",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066764,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;Ultrasound guided aspiration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chest radiograph shows&nbsp;<strong>Unilateral Left pleural effusion</strong>. In the absence of suspicion for transudative effusion, thoracocentesis is indicated in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong>&nbsp;<strong>Suction </strong>with percussion physiotherapy is recommended in suspected collapse due to mucus plugging etc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Antibiotics</strong> are initiated if suspicion of severe CAP is present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Chest physiotherapy</strong> is given to reduce collapse and pulmonary rehabilitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture32.jpg\" alt=\"\" width=\"500\" height=\"607\"></p>",
      "correct_choice_id": 45949,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11440,
      "choices": [
        {
          "id": 45726,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benzathine penicillin 2.4 million units weekly for three weeks</span></span></span></span></p>"
        },
        {
          "id": 45727,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benzathine penicillin 2.4 million units as single dose</span></span></span></span></p>"
        },
        {
          "id": 45728,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tetracycline 2g daily</span></span></span></span></p>"
        },
        {
          "id": 45729,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benzathine penicillin 12-24 million units for 21 days</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is used in the treatment of late cardiovascular syphilis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q1244717",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066731,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Benzathine penicillin 2.4 million units weekly for three weeks.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late cardiovascular syphilis is a form of tertiary syphilis that typically requires intensive antibiotic treatment to effectively manage the disease. The recommended regimen for treating this condition involves the administration of Benzathine penicillin G at a dose of 2.4 million units administered intramuscularly once a week for a total of three weeks. This regimen is effective because it maintains a therapeutic level of penicillin in the blood over a prolonged period, which is necessary for eradicating the persistent Treponema pallidum bacteria responsible for syphilis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-155546.png\" style=\"height:717px; width:1000px\" /></p>",
      "correct_choice_id": 45726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11470,
      "choices": [
        {
          "id": 45846,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nothing, since CT was normal</span></span></span></span></p>"
        },
        {
          "id": 45847,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start on aspirin + clopidogrel</span></span></span></span></p>"
        },
        {
          "id": 45848,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous thrombolysis</span></span></span></span></p>"
        },
        {
          "id": 45849,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Advice BP control</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with left-sided facial paralysis and weakness for the past 1 hour. Her blood pressure is 160/100 mmHg and CT shows dense MCA sign. What would be your next step? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q6247268",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Intravenous thrombolysis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation of acute left-sided facial paralysis and weakness, alongside the finding of a dense MCA (Middle Cerebral Artery) sign on a CT scan, indicates an acute ischemic stroke. The dense MCA sign is a radiologic indicator of a thrombus or embolus in the MCA, which is one of the most common sites for cerebral infarctions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given that the symptoms began only 1 hour ago and the CT has confirmed the location of the occlusion without showing any signs of hemorrhage or extensive infarction (which would contraindicate thrombolysis), intravenous thrombolysis is the most appropriate intervention. This treatment is aimed at dissolving the clot and restoring blood flow to the affected area of the brain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture57.jpg\" style=\"height:304px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Nothing, since CT was normal:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect because the CT was not normal; it showed a dense MCA sign, indicating an acute stroke.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Start on aspirin + clopidogrel:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This would generally be considered in secondary prevention after the acute management phase of ischemic stroke, or if the patient was not a candidate for thrombolysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Advice BP control:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While controlling blood pressure is important, it is not the immediate next step in the management of a patient showing signs of acute ischemic stroke with a window for thrombolysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of acute ischemic stroke with clear indications, intravenous thrombolysis should be administered as soon as possible within the therapeutic window to improve outcomes. Immediate evaluation and management are critical to maximize recovery and minimize long-term disability.</span></span></span></span></p>",
      "correct_choice_id": 45848,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11472,
      "choices": [
        {
          "id": 45854,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute kidney injury (AKI)</span></span></span></span></p>"
        },
        {
          "id": 45855,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute glomerulonephritis</span></span></span></span></p>"
        },
        {
          "id": 45856,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic renal failure</span></span></span></span></p>"
        },
        {
          "id": 45857,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephrotic syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AKIN and RIFLE criteria are used to classify? (AIIMS MAY 2019)</span></span></p>",
      "unique_key": "Q7036371",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066751,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Acute Kidney Injury (AKI)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The AKIN (Acute Kidney Injury Network) and RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) criteria are specifically designed to classify and diagnose Acute Kidney Injury (AKI). These criteria help in early detection and grading the severity of AKI based on changes in serum creatinine, urine output, and duration of symptoms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Current diagnosis is based on the <strong>KDIGO group criteria</strong>. Urine output (OR) Creatinine rise is considered in the diagnosis. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KDIGO group criteria for diagnosis of AKI:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in S. Creatinine &ge; 0.3mg/dL.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in S. Creatinine &ge; 1.5 times of baseline that is known/presumed to have occur in the past 7 days.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine volume &lt; 0.5ml/kg/hour for 6 hours.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture43.jpg\" style=\"height:268px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Acute glomerulonephritis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This has specific clinical and laboratory features distinct from AKI.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Chronic renal failure:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by a gradual loss of kidney function over months to years.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Nephrotic syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defined by high levels of protein in the urine, low levels of protein in the blood, high levels of cholesterol, and swelling.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The AKIN and RIFLE criteria are essential tools for diagnosing and assessing the severity of Acute Kidney Injury, which can guide interventions and predict outcomes in affected patients. They emphasize changes in serum creatinine and urine output as key indicators of kidney function.</span></span></span></span></p>",
      "correct_choice_id": 45854,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11497,
      "choices": [
        {
          "id": 45954,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral malaria</span></p>"
        },
        {
          "id": 45955,
          "text": "<p><span style=\"font-size:12.0pt;\">Leptospirosis</span></p>"
        },
        {
          "id": 45956,
          "text": "<p><span style=\"font-size:12.0pt;\">Brucellosis</span></p>"
        },
        {
          "id": 45957,
          "text": "<p><span style=\"font-size:12.0pt;\">Typhoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Following is a graphic representation of a patient admitted in medicine ward with fever. What could be the possible diagnosis? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture33.jpg\" alt=\"\" width=\"300\" height=\"179\"></span></p>",
      "unique_key": "Q2289665",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066766,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Leptospirosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image shows typical&nbsp;<strong>biphasic illness with initial leptospiremic</strong> <strong>phase&nbsp;</strong>followed by immune phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other illness that shows biphasic pattern include measles, Tick borne encephalitis virus, rarely Zika virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Modified Faine Criteria </strong></i><strong>is used for diagnosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture34.jpg\" alt=\"\" width=\"600\" height=\"386\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Monophasic illness with predominant CNS and multisystem involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Undulant fever presenting with PUO, muscle pain, thoracic backpain</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. Enteric fever causes step ladder pattern of fever.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leptospirosis should be considered in patients presenting with a biphasic fever pattern, especially when supported by epidemiologic data pointing to possible exposure to contaminated water or animals. Early diagnosis and treatment are crucial to prevent complications such as Weil's disease, which can lead to severe renal and hepatic issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Leptospirosis/Chap 184</strong></span></p>",
      "correct_choice_id": 45955,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11471,
      "choices": [
        {
          "id": 45850,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop the treatment and follow up</span></span></span></span></p>"
        },
        {
          "id": 45851,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue treatment for another 2 years</span></span></span></span></p>"
        },
        {
          "id": 45852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gradually taper the drug and stop treatment</span></span></span></span></p>"
        },
        {
          "id": 45853,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue lifelong treatment with antiepileptics</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old who is taking antiepileptics, has had a seizure-free period of 6 months. She has no family history of epilepsy. Her EEG is now normal and she has a normal neurological exam and intelligence. What would be your advice? (AIIMS MAY 2019)</span></span></span></span></p>",
      "unique_key": "Q3903577",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066750,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Continue treatment for another 2 years </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of epilepsy, particularly in children and adolescents, the continuation of antiepileptic drug (AED) therapy after a period of being seizure-free is typically recommended for about 2 years. This recommendation is based on the need to stabilize neurological function and minimize the risk of recurrence. The decision to discontinue AEDs should consider factors such as the duration of being seizure-free, EEG findings, the type of epilepsy, and the individual&rsquo;s neurological examination.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rationale for Continuing Treatment:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continuing AED treatment for at least 2 years after achieving seizure control helps ensure the stability of the condition and reduces the likelihood of seizure recurrence, especially during the critical developmental years of adolescence.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrences are most common in the first 3 months after discontinuing AEDs, making a cautious approach necessary.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stop the treatment and follow up:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This would be risky given the short period of seizure freedom (only 6 months). Stopping treatment prematurely may lead to recurrence.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Gradually taper the drug and stop treatment:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is typically considered after a longer period of seizure freedom, usually a minimum of 2 years, not just 6 months.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Continue lifelong treatment with antiepileptics:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is generally reserved for cases of refractory epilepsy where seizures cannot be controlled with multiple medications, which does not seem to be the case here based on the information provided.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-epileptics once initiated <strong>must be continued for a minimum period of 2 years</strong>. Decision to stop AED is considered if, <strong>seizure free &gt; 2 years with normal MRI, EEG, seizure</strong> <strong>type</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrences occur in the first 3 months of discontinuing AED.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison principles of internal Medicine 21st edition Pg. 12076</span></span></strong></span></span></p>",
      "correct_choice_id": 45851,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11418,
      "choices": [
        {
          "id": 45638,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Increased activity of lipoprotein lipase and decreased activity of hormone sensitive lipase </span></span></span></span></p>"
        },
        {
          "id": 45639,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Increased activity of hormone sensitive lipase and decreased lipoprotein lipase activity</span></span></span></span></p>"
        },
        {
          "id": 45640,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Increase in peripheral function of LDL receptors</span></span></span></span></p>"
        },
        {
          "id": 45641,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Increased in activity of hepatic lipase</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The value of TG and VLDL are high in chronic diabetes because of which of the following reasons: (AIIMS MAY 2017)</span></span></span></p>",
      "unique_key": "Q5274514",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066719,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Increased activity of hormone sensitive lipase and decreased lipoprotein lipase activity.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In chronic diabetes, increase in hormone sensitive lipase and decrease in lipoprotein is seen, due to which values of TG and VLDL are increased. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin has inhibitory effect on hormone sensitive lipase</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. In diabetes, low insulin corresponds to an increase in hormone sensitive lipase activity. This <strong>promotes breakdown of lipids and release of TG, and free fatty acids</strong> from the adipose tissue. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin induces the activity of lipoprotein lipase, which is present on capillary walls</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. LPL promotes hydrolysis of TG and degradation of transport proteins, VLDL and chylomicrons. In diabetes, low insulin leads to decreased LPL activity which corresponds to increase in VLDL and TG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Increased activity of lipoprotein lipase and decreased activity of hormone sensitive lipase:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because in diabetes, the activities of these enzymes are reversed; HSL activity is increased, and LPL activity is decreased.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Increase in peripheral function of LDL receptors:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because LDL receptor function generally affects LDL levels, not directly influencing VLDL or triglyceride levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Increased in activity of hepatic lipase:</span></strong><span style=\"font-size:12.0pt\"> Incorrect for this context as hepatic lipase primarily affects the metabolism of HDL and to a lesser extent LDL, not directly impacting TG and VLDL levels in the way described for this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In chronic diabetes, the combination of increased hormone sensitive lipase activity (due to low insulin levels) and decreased lipoprotein lipase activity leads to higher levels of triglycerides and VLDL. This reflects the central role of insulin in lipid metabolism regulation.</span></span></span></p>",
      "correct_choice_id": 45639,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11427,
      "choices": [
        {
          "id": 45674,
          "text": "<p><span style=\"font-size:12.0pt;\">Rosuvastatin + fenofibrate</span></p>"
        },
        {
          "id": 45675,
          "text": "<p><span style=\"font-size:12.0pt;\">Atorvastatin 80 mg</span></p>"
        },
        {
          "id": 45676,
          "text": "<p><span style=\"font-size:12.0pt;\">Fenofibrate</span></p>"
        },
        {
          "id": 45677,
          "text": "<p><span style=\"font-size:12.0pt;\">Rosuvastatin 10 mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man, post-MI, had the following lab values. Which of the following must be his treatment plan?</span><span style=\"color:black;font-size:12.0pt;\"> (AIIMS MAY 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">LDL - 125mg/dl</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">HDL - 33mg/dl</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TGL - 270mg/dl</span></p>",
      "unique_key": "Q3836674",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066723,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Atorvastatin 80 mg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Post-MI patients require aggressive management to reduce the risk of future cardiovascular events. The lab values indicate elevated LDL and triglycerides, along with low HDL. The treatment plan includes the use of high-intensity statin therapy, which is recommended to significantly lower LDL cholesterol as part of secondary prevention strategies in atherosclerotic cardiovascular disease (ASCVD). Atorvastatin 80 mg falls under the category of high-intensity statins and is effective in lowering LDL cholesterol significantly, which helps in reducing the risk of recurrent cardiovascular events.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rosuvastatin + fenofibrate:</strong> This combination might be considered if there were specific concerns about triglyceride levels that could not be managed by statin therapy alone. However, the primary goal post-MI is to manage LDL levels aggressively with high-intensity statins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fenofibrate:</strong> Fenofibrate primarily targets triglycerides and would not be the first choice when the primary objective is to lower LDL cholesterol post-MI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rosuvastatin 10 mg:</strong> While rosuvastatin is effective in lowering LDL cholesterol, a lower dose may not be sufficient for high-risk patients post-MI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The high-intensity statin therapy, such as atorvastatin 80 mg, is essential in the management of patients after an MI to reduce the risk of subsequent cardiovascular events, regardless of initial cholesterol levels. This approach aligns with guidelines that emphasize aggressive LDL reduction in patients with established cardiovascular disease.</span></p>",
      "correct_choice_id": 45675,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11500,
      "choices": [
        {
          "id": 45966,
          "text": "<p><span style=\"font-size:12.0pt;\">The survival rate of graft is 95% in the first year</span></p>"
        },
        {
          "id": 45967,
          "text": "<p><span style=\"font-size:12.0pt;\">The life expectancy is doubled in a diabetic patient with renal transplant</span></p>"
        },
        {
          "id": 45968,
          "text": "<p><span style=\"font-size:12.0pt;\">The transplantation is cost effective after the second transplant year</span></p>"
        },
        {
          "id": 45969,
          "text": "<p><span style=\"font-size:12.0pt;\">The treatment of chronic rejection has improved over the last 10 years</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A diabetic nephropathy patient is an ideal candidate for renal graft transplant. Which of the following statements is true? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q5419973",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066768,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;The transplantation is cost effective after the second transplant year</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the absence of graft rejection, <strong>transplantation is financially advantageous for a patient with diabetic nephropathy.</strong> When compared to two years of dialysis, transplant surgery is less expensive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.<strong> </strong>Graft survival rate is ~80-82% at the end of first year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.<strong> </strong>The life expectancy of a patient with diabetic nephropathy is not doubled post-transplant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. Chronic graft rejection following renal transplantation is referred to as <strong>chronic allograft nephropathy (CAN)</strong> which consists of tubular atrophy, glomerulosclerosis, fibrosis of the renal interstitium, and fibrous thickening of the arteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HLA mismatching, acute episodes of graft rejection, age mismatch between donor and recipient, smoking, and acute episodes of graft rejection</strong> are risk factors that put a recipient at risk for long-term graft rejection. <strong>Treatment is difficult and no significant improvement has been seen over last 10 years</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Renal transplantation becomes cost-effective after the second year post-transplant for diabetic nephropathy patients compared to ongoing dialysis. This consideration, coupled with improved quality of life and potential prolongation of life expectancy, makes it a favorable option for suitable candidates.</span></p>",
      "correct_choice_id": 45968,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11400,
      "choices": [
        {
          "id": 45566,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Aminoglycoside and colistin</span></p>"
        },
        {
          "id": 45567,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cotrimoxazole with 3rd generation cephalosporin</span></p>"
        },
        {
          "id": 45568,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Carbapenems and 3rd generation cephalosporin</span></p>"
        },
        {
          "id": 45569,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cefepime and tigecycline</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 43-year-old patient presented with spikes of fever and difficulty in breathing. Transesophageal echo revealed vegetations in the heart. The culture was positive for Burkholderia cepacia. Which of the following is the first line of management? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q6175202",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066712,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cotrimoxazole with 3rd generation cephalosporins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is B, Cotrimoxazole with 3rd generation cephalosporins. This combination is effective against Burkholderia cepacia, a pathogen known for its resistance to many standard antibiotics. The standard regimen includes Cotrimoxazole (trimethoprim-sulfamethoxazole), which has broad-spectrum bacterial coverage, combined with a 3rd generation cephalosporin such as ceftazidime or cefoperazone-sulbactam to cover for the pathogen's unique resistance profiles and aggressive infection nature, especially in immunocompromised patients or those with existing cardiac issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aminoglycoside and colistin:</strong> This option is incorrect due to the intrinsic resistance of Burkholderia cepacia to aminoglycosides. While colistin could still be effective, the resistance to aminoglycosides limits this combination's usefulness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbapenems and 3rd generation cephalosporin:</strong> Incorrect because the combination of carbapenems with cephalosporins is generally not recommended. They both share a similar mechanism of action, inhibiting bacterial cell wall synthesis, and could potentially compete for the same binding sites, thus reducing their effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cefepime and tigecycline:</strong> Incorrect because tigecycline is not particularly effective against Burkholderia cepacia. Cefepime alone would not sufficiently manage the infection due to the bacteria's robust resistance profile.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The standard regimen for Burkholderia cepacia is cotrimoxazole with ceftazidime /cefoperazone-sulbactam.</span></p>",
      "correct_choice_id": 45567,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11485,
      "choices": [
        {
          "id": 45906,
          "text": "<p><span style=\"font-size:12.0pt;\">22 mmol/L</span></p>"
        },
        {
          "id": 45907,
          "text": "<p><span style=\"font-size:12.0pt;\">10 mmol/L</span></p>"
        },
        {
          "id": 45908,
          "text": "<p><span style=\"font-size:12.0pt;\">16 mmol/L</span></p>"
        },
        {
          "id": 45909,
          "text": "<p><span style=\"font-size:12.0pt;\">12 mmol/L</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Calculate the anion gap from the following values: Na+ = 137 mmol/L; K+ = 4 mmol/L; CI- =100 mmol/L; HCO3- = 15 mmol/L? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q4520040",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066761,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 22 mmol/L</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AG = (Sum of cation) - (Sum of anion)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AG = (Na - (HCO3 + CL))</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AG = 137 – 115 = 22 mmol/L</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note:&nbsp;</strong>Normal AG ~ 12</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture49.jpg\" alt=\"\" width=\"1000\" height=\"526\"></span></p>",
      "correct_choice_id": 45906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11504,
      "choices": [
        {
          "id": 45982,
          "text": "<p><span style=\"font-size:12.0pt;\">Seizures</span></p>"
        },
        {
          "id": 45983,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 45984,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral neuropathy</span></p>"
        },
        {
          "id": 45985,
          "text": "<p><span style=\"font-size:12.0pt;\">Uremic pericarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Dialysis will prevent all except? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q6646423",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066770,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Peripheral Neuropathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dialysis is effective in removing many waste products and toxins from the blood, which can alleviate a range of symptoms associated with uremia. However, it is less effective in preventing or reversing complications that arise from the accumulation of middle molecular weight substances, such as those implicated in peripheral neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture35.jpg\" alt=\"\" width=\"1000\" height=\"314\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peripheral neuropathy in dialysis patients is largely attributed to the build-up of middle molecular weight molecules like beta 2 microglobulin, which are not efficiently removed by standard dialysis membranes. Native kidneys or high-flux dialyzers are more effective at removing these molecules, but even these can have limited efficacy. Peripheral neuropathy is thus a complication less responsive to conventional dialysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Seizures:&nbsp;</strong>These are often caused by severe uremia or electrolyte imbalances, both of which can be effectively managed through dialysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metabolic acidosis:&nbsp;</strong>Dialysis helps correct metabolic acidosis by removing excess acids from the blood and restoring bicarbonate levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Uremic pericarditis:&nbsp;</strong>Uremic toxins that contribute to inflammatory conditions such as pericarditis are effectively removed through dialysis, thereby preventing this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While dialysis effectively manages many complications of renal failure such as seizures, metabolic acidosis, and uremic pericarditis, it is less effective for peripheral neuropathy due to its limited ability to remove middle molecular weight toxins that contribute to nerve damage. Ongoing management and treatment strategies need to consider these limitations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Nephrology, Dialysis</strong></span></p>",
      "correct_choice_id": 45984,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11398,
      "choices": [
        {
          "id": 45558,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Fever persisting for more than 3 weeks</span></p>"
        },
        {
          "id": 45559,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Immunocompromised status should be ruled out</span></p>"
        },
        {
          "id": 45560,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Undiagnosed after one week of investigation</span></p>"
        },
        {
          "id": 45561,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Temperature more than 38.3° C</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Definition of PUO includes all of the following except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q3748341",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066711,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Undiagnosed after one week of investigation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is C because the definition of Pyrexia of Unknown Origin (PUO) does not specify that the fever must remain undiagnosed for only one week. According to the established criteria for diagnosing PUO, the investigation can be longer and more thorough before labeling a fever as PUO. The criteria include a fever exceeding 38.3°C on at least two occasions, persisting for more than three weeks, and a diagnosis that remains uncertain after comprehensive history taking, physical examinations, and routine investigations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fever persisting for more than 3 weeks:</strong> This is incorrect&nbsp;because it is a part of the definition of PUO, where the fever must last for more than three weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Immunocompromised status should be ruled out:</strong> This is incorrect&nbsp; as a choice because being non-immunocompromised is a criterion in the diagnosis of PUO, which means any immunocompromised status should indeed be ruled out.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Temperature more than 38.3°C:</strong> This is also incorrect as it is part of the criteria, where the temperature must be more than 38.3°C on multiple occasions to consider it as PUO.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for diagnosis of PUO:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Fever &gt; 38.3 degrees C (101° F) on 2 occasions.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Duration &gt; 3 weeks.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Not immunocompromised state.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Diagnosis not certain after history, physical examination and routine and obligatory investigations.</span></li></ul>",
      "correct_choice_id": 45560,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11640,
      "choices": [
        {
          "id": 46526,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        },
        {
          "id": 46527,
          "text": "<p><span style=\"font-size:12.0pt;\">4.5</span></p>"
        },
        {
          "id": 46528,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 46529,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 25yr old woman came to OPD one year after the birth of her last child. She had been treated for iron deficiency anemia while pregnant. On examination, she is pale, and investigations show a HB of 5mg/dl and a reticulocyte count of 9%. What is her corrected reticulocyte count ? (take normal Hb as 15mg/dl) (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q8710483",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066778,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Corrected reticulocyte count (CRC)= reticulocyte % X (actual Hb/normal Hb)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC= 9 X 5/15 = 3%</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC can also be calculated using hematocrit</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CRC= Reticulocyte % X (Actual PCV/ normal PCV )</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corrected reticulocyte count (CRC) adjusts the observed reticulocyte percentage to reflect the degree of anemia by using the patient's actual hemoglobin compared to a normal hemoglobin level.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The corrected reticulocyte count is crucial for assessing bone marrow response in anemic patients, providing insight into whether the bone marrow is responding appropriately to the anemia. This is particularly important in managing patients with iron deficiency anemia to monitor recovery or response to therapy.</span></p>",
      "correct_choice_id": 46528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11512,
      "choices": [
        {
          "id": 46014,
          "text": "<p><span style=\"font-size:12.0pt;\">Age &lt; 60 years</span></p>"
        },
        {
          "id": 46015,
          "text": "<p><span style=\"font-size:12.0pt;\">Duration of TIA &gt; 5 mins</span></p>"
        },
        {
          "id": 46016,
          "text": "<p><span style=\"font-size:12.0pt;\">SBP &gt; 140 mm Hg and DBP &lt; 90 mmHg</span></p>"
        },
        {
          "id": 46017,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All of the factors would suggest a higher risk for a patient with TIA developing stroke in the future according to ABCD2 scoring except? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q2620664",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066741,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Age &lt; 60 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ABCD2 score is a clinical tool used to predict the short-term risk of stroke after a transient ischemic attack (TIA). The scoring system includes several factors that help assess this risk. Here’s why option A is the correct answer:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Age &lt; 60 years:&nbsp;</strong>According to the ABCD2 scoring system, a patient who is aged 60 years or older scores 1 point, indicating a higher risk. Therefore, being younger than 60 does not contribute to an increased score, making it the correct choice for the exception in this question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Duration of TIA &gt; 5 mins:&nbsp;</strong>In the ABCD2 score, the duration of the TIA is an important factor. TIA lasting 10-59 minutes scores 1 point, and TIA lasting more than 60 minutes scores 2 points. Duration less than 10 minutes would score 0. However, since the option simply says \"Duration of TIA &gt; 5 mins,\" without specifying how much longer, it's less clearly defined in this question, but generally longer durations imply a higher score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. SBP &gt; 140 mm Hg and DBP &lt; 90 mmHg:&nbsp;</strong>High blood pressure at the time of TIA, defined as SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg, scores 1 point in the ABCD2 score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diabetes:&nbsp;</strong>The presence of diabetes in a patient who has experienced a TIA adds 1 point to the ABCD2 score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture39.jpg\" alt=\"\" width=\"1000\" height=\"365\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additional D3-Dual TIA (within 7 days of first TIA), Imaging (MRI, DWI) were added to original score. However, all these perform very poorly in the light of recent evidences.</span></p>",
      "correct_choice_id": 46014,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11448,
      "choices": [
        {
          "id": 45758,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skimmed Milk</span></span></span></span></p>"
        },
        {
          "id": 45759,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Condensed Milk</span></span></span></span></p>"
        },
        {
          "id": 45760,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ice-cream</span></span></span></span></p>"
        },
        {
          "id": 45761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yogurt</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old man presented with diarrhea and intolerance to dairy products. On investigation, he was found to have a lactase deficiency. Which of the following agents is least likely to cause symptoms of lactose intolerance? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q6036865",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066736,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Yogurt</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yogurt is the least likely to cause symptoms of lactose intolerance among the options listed. This is because yogurt contains live bacteria, specifically lactobacilli, which help to break down lactose. This fermentation process reduces the lactose content significantly, making yogurt easier to digest for individuals with lactase deficiency. Additionally, these bacteria can contribute to the production of some lactase enzyme, aiding in the digestion of any remaining lactose.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Skimmed Milk:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contains nearly the same amount of lactose as regular milk, just with less fat. It is likely to cause symptoms in someone with lactose intolerance.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Condensed Milk:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Even higher in lactose because it is milk that has been concentrated by removing water. High lactose content makes it more likely to cause intolerance symptoms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ice-cream:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typically high in lactose because it is made from cream and milk, both of which are high in lactose. Ice cream can also contain mix-ins and flavorings that increase the lactose content.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yogurt contains lactobacillus, that helps in lactase production and also low lactose levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Gastroenterology/Diarrhea/chap 471</span></span></strong></span></span></p>",
      "correct_choice_id": 45761,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11634,
      "choices": [
        {
          "id": 46502,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperphosphatemia</span></span></span></p>"
        },
        {
          "id": 46503,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperuricemia </span></span></span></p>"
        },
        {
          "id": 46504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypercalcemia </span></span></span></p>"
        },
        {
          "id": 46505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperkalemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not seen in tumor lysis syndrome ? (AIIMS NOV 2017)</span></span></span></p>",
      "unique_key": "Q9937810",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066773,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hypercalcemia&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor lysis syndrome occurs due to destruction of large no of rapidly proliferating neoplstic cells. It is characterised by Hyperuricemia, hyperkalemia , hyperphosphasphatemia, hypocalcemia, acidosis, acute renal failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It mainly occurs after initiation of chemotherapy and is diagnosed by Cairo bishop criteria (includes both lab and clinical features)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Management includes - allopurinol , rasburicase along with aggressive hydration .</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hyperphosphatemia</span></strong><span style=\"font-size:12.0pt\">: Typically occurs as phosphate is released from lysed tumor cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hyperuricemia</span></strong><span style=\"font-size:12.0pt\">: Results from the metabolism of nucleic acids from destroyed cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hyperkalemia</span></strong><span style=\"font-size:12.0pt\">: Occurs due to the release of potassium from the intracellular to the extracellular space.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In tumor lysis syndrome, the rapid breakdown of tumor cells leads to <strong>hypocalcemia</strong>, not hypercalcemia, making this the key distinguishing feature in identifying the condition. Management strategies like hydration, use of allopurinol, or rasburicase are critical in preventing renal failure and other serious complications.</span></span></span></p>",
      "correct_choice_id": 46504,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11430,
      "choices": [
        {
          "id": 45686,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspartate aminotransferases /platelet ratio</span></p>"
        },
        {
          "id": 45687,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibro test</span></p>"
        },
        {
          "id": 45688,
          "text": "<p><span style=\"font-size:12.0pt;\">Forns index</span></p>"
        },
        {
          "id": 45689,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum laminin &amp; serum hyaluronidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Noninvasive test to detect hepatic fibrosis include?</span><span style=\"color:black;font-size:12.0pt;\"> (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q8240132",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066726,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Fibro test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The FibroTest, also known as the Fibro test, is a noninvasive, blood-based test designed specifically to detect hepatic fibrosis. This test calculates the degree of liver fibrosis using a combination of several serum biochemical markers including haptoglobin, bilirubin, gamma-glutamyl transpeptidase (GGT), apolipoprotein A1, and alpha-2 macroglobulin. It evaluates liver damage and fibrosis by measuring these markers, which are affected by liver function and architecture changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspartate aminotransferases /platelet ratio (APRI):</strong> Incorrect as it is primarily used to estimate the likelihood or severity of fibrosis rather than to directly detect it. It correlates with the degree of liver fibrosis but is less specific.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Forns index:</strong> Incorrect for the same reason as APRI. The Forns index is used to assess the risk of developing liver fibrosis based on variables including age, platelet count, cholesterol levels, and GGT, but it does not directly measure fibrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Serum laminin &amp; serum hyaluronidase:</strong> Incorrect as these are not standard tests for directly detecting hepatic fibrosis; they can indicate changes in extracellular matrix turnover but are less specific and commonly used compared to the FibroTest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fibro test is a sensitive test to detect hepatic fibrosis. It is a <strong>multiparameter blood test</strong> which incorporate haptoglobin, bilirubin, GGT, apolipoprotein A1, and alpha-2 macroglobulin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Test for estimating risk developing hepatic fibrosis:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">AST/platelet ratio</span></li><li><span style=\"font-size:12.0pt;\">Forns index</span></li><li><span style=\"font-size:12.0pt;\">Fib-4</span></li><li><span style=\"font-size:12.0pt;\">Cirrhosis determinant score.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Test for detecting hepatic fibrosis: <strong>Fibro test</strong>.</span></p>",
      "correct_choice_id": 45687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11447,
      "choices": [
        {
          "id": 45754,
          "text": "<p><span style=\"font-size:16px;\">HBsAg, IgM anti-HBc, Anti-HCV, Anti HEV</span></p>"
        },
        {
          "id": 45755,
          "text": "<p><span style=\"font-size:16px;\">Anti-HAV, HBsAg, IgM anti-HBc, Anti-HCV</span></p>"
        },
        {
          "id": 45756,
          "text": "<p><span style=\"font-size:16px;\">HBsAg, IgM anti-HBc, Anti-HDV, Anti-HEV, Anti-HCV</span></p>"
        },
        {
          "id": 45757,
          "text": "<p><span style=\"font-size:16px;\">Anti-HAV, IgM anti-HBc, Anti-HCV, Anti-HEV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 40-year-old male chronic smoker presents to the AIIMS OPD with fever, fatigue, yellow-colored urine, and RUQ pain. For the past few days, he has developed an aversion to eating food. On examination icterus was present. What investigations would you advise to rule out acute viral hepatitis? (AIIMS MAY 2018)</span></p><p><br><span style=\"font-size:16px;\">Liver function test results are given below:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Total Bilirubin 18.5</span></li><li><span style=\"font-size:16px;\">Direct Bilirubin 10.5&nbsp;&nbsp;&nbsp;</span></li><li><span style=\"font-size:16px;\">SGOT/AST 723</span></li><li><span style=\"font-size:16px;\">SGPT/ALT 812</span></li></ul>",
      "unique_key": "Q8239575",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066735,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Anti-HAV, HBsAg, IgM anti-HBc, Anti-HCV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Above history is suggestive of acute viral hepatitis with ALT&gt;AST and elevated &gt;10X times. With resolution of symptoms jaundice gradually increases and spontaneously improves.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Common causes of AST, ALT &gt; 10X are Viral Hepatitis (B, A, C-rare, E-In pregnancy/Post-transplant), Toxins, Shock liver, Fulminant Wilsons.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. </strong>Anti-HEV testing routinely not employed</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C.&nbsp;</strong>Hepatitis D usually causes severe disease when B+D coinfection occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.&nbsp;</strong>HbsAg is first test of hep B infection W/IgM HbC suggest FLARE, window period, acute infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In cases of suspected acute viral hepatitis with significant liver enzyme elevation and icterus, it's essential to conduct a thorough serological evaluation to determine the specific type of hepatitis virus involved. This allows for targeted management and appropriate precautions to prevent transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Reference: Harrison/gastroenterology/Viral Hepatitis/Chap 339</strong></span></p>",
      "correct_choice_id": 45755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11442,
      "choices": [
        {
          "id": 45734,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin</span></span></span></span></p>"
        },
        {
          "id": 45735,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftriaxone</span></span></span></span></p>"
        },
        {
          "id": 45736,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Azithromycin</span></span></span></span></p>"
        },
        {
          "id": 45737,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Streptomycin</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs is commonly used for treating community-acquired pneumonia in OPD? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q9847000",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066732,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Azithromycin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decision for OPD vs Admission for CAP is <strong>assessed by CURB-65, PSI score</strong>. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For patients with risk factors (CKD, non-ambulator, Recent ABx, hospitalization last 3 months), macrolide + Beta-lactam /Respiratory FQ preferred. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin given only if CA-MRSA is considered.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suspicion for MRSA:</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Necrotizing/Cavitary pneumonia</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pleural based nodules</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post viral pneumonia</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment failure (Sx, hypoxemia, MODS @ 72 hours post admission)</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IVDU</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftriaxone is given for IP treatment and administered I.V.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Streptomycin is not used in management of CAP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Azithromycin is a commonly used antibiotic for the outpatient treatment of community-acquired pneumonia due to its effectiveness against a wide range of respiratory pathogens and its patient-friendly dosing schedule.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Respiratory /Pneumonia/Chapter 126</span></span></strong></p>",
      "correct_choice_id": 45736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11510,
      "choices": [
        {
          "id": 46006,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 46007,
          "text": "<p><span style=\"font-size:12.0pt;\">Fiberoptic bronchoscopy</span></p>"
        },
        {
          "id": 46008,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Thorax</span></p>"
        },
        {
          "id": 46009,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchography</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 50-year-old chronic smoker presented with mild recurrent hemoptysis without fever or weight loss. The chest X-ray appears normal and the sputum is negative for AFB. Which of the following is the most useful diagnostic investigation? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q4486655",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066776,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;CT Thorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CECT is preferred</strong> <strong>when suspicion of malignancy is high</strong>. HRCT is preferred to look at lung parenchyma/suspected ILD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>MRI is <strong>used to assess for metastasis, secondary changes</strong>. MRI is NOT preferred over CT scan for evaluation of distant metastasis and invasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Bronchoscopy is used for biopsy of mass based on accessibility. More central masses are amenable to bronchoscopic biopsy. Peripheral masses are sampled by CT-guided biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Bronchography is no longer used in today’s practice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The choice of CT Thorax (HRCT or CECT) is critical for early detection of potential malignancies or other significant lung conditions in a high-risk individual, particularly when initial less sensitive tests like chest X-ray and sputum analysis have failed to elucidate the cause of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - (Harrison 21E, 597,598) Resp Med/Hemoptysis/Lung CA</strong></span></p>",
      "correct_choice_id": 46008,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11474,
      "choices": [
        {
          "id": 45862,
          "text": "<p><span style=\"font-size:12.0pt;\">Risk of thrombosis strongly correlates with the degree of thrombocytosis</span></p>"
        },
        {
          "id": 45863,
          "text": "<p><span style=\"font-size:12.0pt;\">It is protective against H. pylori infection</span></p>"
        },
        {
          "id": 45864,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized pruritus is a consequence of mast cell activation by JAK 2 mutation</span></p>"
        },
        {
          "id": 45865,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute myeloid leukemia is the most common cause of mortality</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about polycythemia vera is true? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q1926209",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066752,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Generalized pruritus is a consequence of mast cell activation by JAK 2 mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. It is commonly associated with a mutation in the JAK2 gene, which can also affect other cell types, including mast cells. Activation of these cells can lead to the release of histamine, which is thought to contribute to the itching or pruritus often experienced by patients, particularly after warm baths or showers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Myeloproliferative neoplasms include PCV, CML, and PMF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Risk of thrombosis strongly correlates with the degree of thrombocytosis:&nbsp;</strong>Incorrect. Although thrombocytosis is present in polycythemia vera, thrombosis risk correlates more significantly with leukocytosis and the presence of JAK2 mutation rather than solely with thrombocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is protective against H. pylori infection:&nbsp;</strong>Incorrect. There is no evidence to suggest that polycythemia vera provides protection against H. pylori infection. Patients with PV actually may have an increased risk of gastrointestinal issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acute myeloid leukemia is the most common cause of mortality:&nbsp;</strong>Incorrect. While patients with polycythemia vera do have an increased risk of transformation to acute myeloid leukemia (AML), the most common cause of mortality in these patients is thrombotic events such as heart attack or stroke.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Generalized pruritus in polycythemia vera, exacerbated by warmth or bathing, is a well-known symptom related to mast cell activation due to the JAK2 mutation. This mutation is a hallmark of the disease and leads to several systemic effects, including increased histamine release, which contributes to pruritus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All MPN can develop AML, Myelofibrosis in the course of the disease.</span></p>",
      "correct_choice_id": 45864,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11508,
      "choices": [
        {
          "id": 45998,
          "text": "<p><span style=\"font-size:12.0pt;\">Responds well to amoxiclav</span></p>"
        },
        {
          "id": 45999,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest X-ray shows bilateral infiltrates</span></p>"
        },
        {
          "id": 46000,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibody are useful in diagnosis</span></p>"
        },
        {
          "id": 46001,
          "text": "<p><span style=\"font-size:12.0pt;\">Can be cultured in a cell-free medium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false about mycoplasma pneumonia? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q7590081",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066775,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Responds well to amoxiclav</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beta-lactam groups of drugs act by inhibiting the transpeptidation process of cell wall synthesis. Mycoplasma does not possess a cell wall and hence is not affected by beta-lactams.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Azithromycin (DOC)</strong>, Doxycycline, Fluoroquinolone (FQ) are effective in management of mycoplasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Interstitial inflammation characterized by bilateral reticular infiltrates are seen on CXR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>IgM, IgG can be used in the diagnosis of Mycoplasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>They show fried-egg appearance on cell free medium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mycoplasma pneumonia does not respond to beta-lactam antibiotics due to its lack of a cell wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred antibiotics for treating Mycoplasma pneumonia include macrolides (e.g., azithromycin), tetracyclines (e.g., doxycycline), and fluoroquinolones for adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Resp Med/pneumonia, Harrison chap 188/5430</strong></span></p>",
      "correct_choice_id": 45998,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11483,
      "choices": [
        {
          "id": 45898,
          "text": "<p><span style=\"font-size:12.0pt;\">Shrinking lung syndrome</span></p>"
        },
        {
          "id": 45899,
          "text": "<p><span style=\"font-size:12.0pt;\">Intra alveolar hemorrhage</span></p>"
        },
        {
          "id": 45900,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleuritis with/without pleural effusion</span></p>"
        },
        {
          "id": 45901,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial inflammation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common pulmonary manifestation of SLE? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q6507467",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066759,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pleuritis with/without pleural effusion.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pleuritis with or without pleural effusion is the most common pulmonary manifestation in patients with SLE. This condition reflects the systemic inflammatory nature of SLE, which frequently affects serous membranes including the pleura. Pleural involvement in SLE typically presents as an exudative pleural effusion, often characterized by pleuritic pain and effusion that can be detected by physical examination and imaging studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture48.jpg\" alt=\"\" width=\"1000\" height=\"1015\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Shrinking lung syndrome:&nbsp;</strong>is very rare occurring in 1% of patients. Some association with <strong>Anti-Ro/La antibodies seen</strong>. No correlation between disease activity, symptoms and antibodies.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>B. Intra Alveolar hemorrhage and D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Interstitial inflammation:&nbsp;</strong>are not the most common presentation.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pleuritis with or without pleural effusion stands out as the most frequent pulmonary complication in SLE due to the disease’s propensity to inflame serous membranes. Accurate diagnosis and effective management of SLE and its pulmonary manifestations are crucial for improving quality of life and reducing morbidity in affected patients.</span></p>",
      "correct_choice_id": 45900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11480,
      "choices": [
        {
          "id": 45886,
          "text": "<p><span style=\"font-size:12.0pt;\">Pantothenate kinase deficiency</span></p>"
        },
        {
          "id": 45887,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuroferritinopathy</span></p>"
        },
        {
          "id": 45888,
          "text": "<p><span style=\"font-size:12.0pt;\">Pelizaeus-Merzbacher disease</span></p>"
        },
        {
          "id": 45889,
          "text": "<p><span style=\"font-size:12.0pt;\">Aceruloplasminemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Tigroid white matter on MRI imaging is seen in which of the following conditions? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q4090903",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066756,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pelizaeus-Merzbacher disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pelizaeus-Merzbacher disease (PMD) is a rare, genetic, demyelinating disorder of the central nervous system characterized by a distinctive \"tigroid\" pattern on MRI. This pattern arises from the preservation of perivascular myelin in the brain's white matter, interspersed with areas of demyelination, creating a striped or tigroid appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pantothenate kinase deficiency:&nbsp;</strong>This condition is also known as PKAN (Pantothenate Kinase-Associated Neurodegeneration). It typically shows a characteristic MRI feature known as the \"eye of the tiger\" sign, which involves a specific pattern of iron deposition in the basal ganglia. The \"eye of the tiger\" sign appears due to a combination of hyperintense signal surrounded by a region of hypointensity on T2-weighted MRI images, reflecting iron accumulation and gliosis. This is distinct from the tigroid pattern seen in demyelinating diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Neuroferritinopathy:&nbsp;</strong>Neuroferritinopathy is another disorder of iron metabolism that affects the brain, leading to iron accumulation, particularly in the basal ganglia. MRI findings in neuroferritinopathy typically do not include the tigroid pattern but may show abnormalities such as signal changes in the basal ganglia related to iron deposition. The imaging features here are more associated with iron accumulation rather than the patchy demyelination that produces the tigroid appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aceruloplasminemia:&nbsp;</strong>Aceruloplasminemia is a rare hereditary disorder characterized by iron accumulation in various tissues, including the brain. Similar to neuroferritinopathy, the primary MRI findings in aceruloplasminemia are related to iron deposition, particularly in the cerebellum and basal ganglia, and do not typically involve the tigroid pattern. Instead, the imaging might show evidence of iron accumulation without the specific changes associated with demyelination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pelizaeus-Merzbacher disease is a prototypical condition that displays a tigroid pattern on MRI. This appearance is due to the patchy preservation and destruction of myelin in the white matter, creating alternating areas of normal myelin and demyelination. This results in the characteristic striped or tigroid appearance on imaging studies, reflective of the disease’s impact on myelination.</span></p>",
      "correct_choice_id": 45888,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11635,
      "choices": [
        {
          "id": 46506,
          "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
        },
        {
          "id": 46507,
          "text": "<p><span style=\"font-size:12.0pt;\">Haptoglobin</span></p>"
        },
        {
          "id": 46508,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferritin</span></p>"
        },
        {
          "id": 46509,
          "text": "<p><span style=\"font-size:12.0pt;\">C-reactive protein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a negative acute phase reactants ? (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q8267879",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066777,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Albumin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Negative acute phase reactants are substances whose serum concentrations decrease in response to systemic inflammation. Albumin is one of the well-recognized negative acute phase reactants. Its levels fall during acute phase response as resources are shifted to produce more critical positive reactants that help in the defense and repair processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm105.jpg\" alt=\"\" width=\"1000\" height=\"823\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Haptoglobin:</strong> This is a positive acute phase reactant, which increases in response to inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ferritin:</strong> Also a positive acute phase reactant, often increases in states of inflammation and infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. C-reactive protein:</strong> A classic positive acute phase reactant, it increases dramatically in response to inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/screenshot-2024-09-10-135926.png\" alt=\"\" width=\"1000\" height=\"1021\"></strong></span></p>",
      "correct_choice_id": 46506,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11461,
      "choices": [
        {
          "id": 45810,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right atrial contraction</span></span></span></span></p>"
        },
        {
          "id": 45811,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closure of tricuspid valve</span></span></span></span></p>"
        },
        {
          "id": 45812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Onset of ventricular systole</span></span></span></span></p>"
        },
        {
          "id": 45813,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maximal atrial filling</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&#39;a&#39; wave in JVP corresponds to? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q4350867",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066746,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Right atrial contraction</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The &#39;a&#39; wave in the jugular venous pulse (JVP) represents right atrial contraction. This occurs towards the end of ventricular diastole and reflects the pressure increase within the right atrium as it contracts to push blood into the right ventricle just before the tricuspid valve closes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Closure of tricuspid valve:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, this would not be specifically represented by an &#39;a&#39; wave; instead, it typically follows the &#39;a&#39; wave and leads into the &#39;c&#39; wave associated with right ventricular contraction.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Onset of ventricular systole:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, ventricular systole corresponds to the &#39;c&#39; wave and the &#39;x&#39; descent on JVP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Maximal atrial filling:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, maximal atrial filling occurs towards the end of the &#39;v&#39; wave and into the &#39;y&#39; descent, which corresponds to passive ventricular filling when the tricuspid valve is open.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture56.jpg\" style=\"height:517px; width:1000px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harrison/Cardiology/Basics of CVS/Chap 239</span></span></strong></span></span></p>",
      "correct_choice_id": 45810,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11458,
      "choices": [
        {
          "id": 45798,
          "text": "<p><span style=\"font-size:12.0pt;\">Brain infarct</span></p>"
        },
        {
          "id": 45799,
          "text": "<p><span style=\"font-size:12.0pt;\">Brainstem injury</span></p>"
        },
        {
          "id": 45800,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic demyelination syndrome</span></p>"
        },
        {
          "id": 45801,
          "text": "<p><span style=\"font-size:12.0pt;\">Rare cause of hypernatremia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year gentleman was referred from outside hospital to AIIMS ER after he developed sudden onset quadriparesis. In hospital patient was treated with 3%NaCl, Oral tolvaptan. Initial metabolic panel revealed Na: 115 mEq/L, K: 2.8 mEq/L, Cl: 85 mEq/L with normal TSH, CBC, RFT, LFT.&nbsp; What is the most likely cause for this patient's condition?&nbsp; (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q7190663",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066743,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Osmotic demyelination syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Previously called central pontine myelinolysis. It occurs due to rapid correction of Chronic Hyponatremia (&gt;8 mg/dL).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Timing:&nbsp;</strong>2-6 days after rapid correction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rx:</strong> Irreversible. Desmopressin clamp if overcorrection in q6h Na values.&nbsp;&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. In Hyponatremia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture53_qnfCv6M.jpg\" alt=\"\" width=\"500\" height=\"453\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. On sudden correction:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture54_956T8fI.jpg\" alt=\"\" width=\"500\" height=\"252\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Risk factors:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Serum sodium ≤ 105 mEq/L</span></li><li><span style=\"font-size:12.0pt;\">Concurrent hypokalemia</span></li><li><span style=\"font-size:12.0pt;\">Chronic excess alcohol intake</span></li><li><span style=\"font-size:12.0pt;\">Acute or chronic hepatic disease</span></li><li><span style=\"font-size:12.0pt;\">Malnourishment</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Brain infarct:&nbsp;</strong>Not directly suggested by the rapid onset of symptoms following electrolyte correction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Brainstem injury:&nbsp;</strong>Could be considered but is less likely without trauma or vascular insult history.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rare cause of hypernatremia:&nbsp;</strong>Not applicable as the condition involves the rapid correction of hyponatremia, not hypernatremia itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rapid correction of chronic hyponatremia should be avoided to prevent the severe neurological complications associated with osmotic demyelination syndrome. Control and monitoring of serum sodium levels are crucial during treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Electrolytes/Chap 53</strong></span></p>",
      "correct_choice_id": 45800,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11409,
      "choices": [
        {
          "id": 45602,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Confused state</span></p>"
        },
        {
          "id": 45603,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Respiratory rate &gt;30/min</span></p>"
        },
        {
          "id": 45604,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Blood urea nitrogen greater than 7mmol/L</span></p>"
        },
        {
          "id": 45605,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Systolic blood pressure less than 100 mm Hg</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">All are components of CURB65 except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q3309073",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066715,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Systolic blood pressure less than 10mm Hg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer, D, specifies a systolic blood pressure less than 100 mm Hg, which is not part of the CURB-65 criteria. The specified threshold for blood pressure in the CURB-65 is ≤90 mm Hg systolic or ≤60 mm Hg diastolic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CURB-65 criteria is <strong>used to assess the severity of illness in case of pneumonia</strong>, especially community acquired pneumonia. It includes 5 variables -</span></p><p>&nbsp;</p><p><span style=\"color:red;font-size:12.0pt;\"><strong>C - C</strong></span><span style=\"font-size:12.0pt;\">onfusion</span></p><p>&nbsp;</p><p><span style=\"color:red;font-size:12.0pt;\"><strong>U - U</strong></span><span style=\"font-size:12.0pt;\">rea&gt;7mmol/L</span></p><p>&nbsp;</p><p><span style=\"color:red;font-size:12.0pt;\"><strong>R - R</strong></span><span style=\"font-size:12.0pt;\">espiratory rate &gt;30/mins</span></p><p>&nbsp;</p><p><span style=\"color:red;font-size:12.0pt;\"><strong>B - B</strong></span><span style=\"font-size:12.0pt;\">lood pressure, SBP &lt;/=90 mmHg or diastolic &lt;/= 60 mmHg</span></p><p>&nbsp;</p><p><span style=\"color:red;font-size:12.0pt;\"><strong>65 - </strong></span><span style=\"font-size:12.0pt;\">Age &gt;/= </span><span style=\"color:red;font-size:12.0pt;\"><strong>65</strong></span><span style=\"font-size:12.0pt;\"> years</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture29.jpg\" alt=\"\" width=\"1000\" height=\"193\"></strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CURB-65 scoring system is used to evaluate pneumonia severity, which does not include systolic blood pressure less than 100 mm Hg but instead sets the threshold at ≤90 mm Hg systolic or ≤60 mm Hg diastolic.</span></p>",
      "correct_choice_id": 45605,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11434,
      "choices": [
        {
          "id": 45702,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthenospermia</span></p>"
        },
        {
          "id": 45703,
          "text": "<p><span style=\"font-size:12.0pt;\">Oligospermia</span></p>"
        },
        {
          "id": 45704,
          "text": "<p><span style=\"font-size:12.0pt;\">Epididymis obstruction</span></p>"
        },
        {
          "id": 45705,
          "text": "<p><span style=\"font-size:12.0pt;\">Undescended testes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Infertility in Kartagener's syndrome is due to which of the following? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q5486806",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066728,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Asthenospermia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Asthenospermia (Immotile sperm [Greek sthenos = strength]</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener result from&nbsp;<strong>loss of function of axonemal dynein that impairs sperm motility</strong>. Respiratory Ciliary dysmotility leads to bronchiectasis and recurrent infections. Association of situs inversus is noted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Oligospermia:&nbsp;</strong>Incorrect because while sperm count can be affected in some genetic or hormonal disorders, in Kartagener's syndrome, the sperm count is typically normal; the issue lies in their motility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Epididymis obstruction:&nbsp;</strong>Incorrect as this is not a feature of Kartagener’s syndrome. While structural anomalies in the reproductive tract can lead to such issues, Kartagener’s syndrome specifically affects the motility of sperm due to ciliary dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Undescended testes:&nbsp;</strong>Incorrect as undescended testes are not associated with Kartagener’s syndrome, which primarily affects ciliary function and not the anatomical position of the testes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infertility in Kartagener's syndrome is primarily due to asthenospermia, which is caused by the immobility of sperm. This immotility results from the genetic defect affecting the dynein arm of sperm flagella, similar to the defect affecting cilia in the respiratory tract, leading to the classic symptoms of the syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Pulmonology/Bronchiectasis/Chapter 290</strong></span></p>",
      "correct_choice_id": 45702,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11517,
      "choices": [
        {
          "id": 46034,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior inferior cerebellar artery</span></p>"
        },
        {
          "id": 46035,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior inferior cerebellar artery</span></p>"
        },
        {
          "id": 46036,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior cerebellar artery</span></p>"
        },
        {
          "id": 46037,
          "text": "<p><span style=\"font-size:12.0pt;\">Basilar artery</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with vertigo, diplopia, hoarseness, dysphagia and left Horner's syndrome associated with numbness of the left face and right-side limbs. Which artery is affected in this patient? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q3951674",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066758,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Posterior inferior cerebellar artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical features are suggestive of Lateral Medullary syndrome/Wallenburg syndrome which occurs due to PICA occlusion. His syndrome is characterized by a range of neurological deficits due to ischemia in the lateral part of the medulla oblongata, where PICA provides blood supply.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Features Associated with PICA Occlusion:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Vertigo and Diplopia:&nbsp;</strong>Caused by the involvement of the vestibular nuclei and adjacent structures.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hoarseness and Dysphagia:&nbsp;</strong>Result from damage to the nucleus ambiguous, affecting the vagal and glossopharyngeal nerve functions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Horner’s Syndrome:&nbsp;</strong>Occurs due to disruption of the sympathetic pathways.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Numbness of the Face and Contralateral Limbs:&nbsp;</strong>Caused by damage to the spinal trigeminal nucleus and the spinothalamic tract, respectively.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anterior Inferior Cerebellar Artery (AICA):&nbsp;</strong>Affects a similar region but typically presents with symptoms like hearing loss due to its supply to the inner ear structures, which is not mentioned in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Superior Cerebellar Artery:&nbsp;</strong>Occlusion typically results in ataxia and coordination difficulties without the cross-sensory loss observed in Wallenberg's Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Basilar Artery:&nbsp;</strong>A much broader array of symptoms would be expected, potentially affecting multiple cranial nerve and long tract functions simultaneously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Image: Arteries involved in brainstem syndromes lateral vs medial brainstem</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture41.jpg\" alt=\"\" width=\"500\" height=\"493\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture42.jpg\" alt=\"\" width=\"1000\" height=\"249\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Chap 426, </strong><i><strong>Neurology/stroke</strong></i></span></p>",
      "correct_choice_id": 46034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11644,
      "choices": [
        {
          "id": 46542,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral glucose challenge test with GH level</span></span></span></p>"
        },
        {
          "id": 46543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin like growth factor 1 binding potein -3 (IGFBP-3 )</span></span></span></p>"
        },
        {
          "id": 46544,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin like growth factor -1 levels</span></span></span></p>"
        },
        {
          "id": 46545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Random growth hormone levels</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 44 yr old man is referred to your center for management of severe hyperglycemia. During examination, you note that patient has enlarged feet, coarse facial features, and prognathism. You suspect acromegaly. Which of the following tests can you use as a screening method for this condition ? (AIIMS NOV 2017)</span></span></span></p>",
      "unique_key": "Q6148826",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066781,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Insulin like growth factor-1 levels</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Acromegaly is a clinical syndrome that results from excessive secretion of growth&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><a href=\"https://www.niddk.nih.gov/Dictionary/H/hormone\" style=\"color:blue; text-decoration:underline\"><span style=\"color:black\">hormone</span></a><span style=\"color:black\">&nbsp;(GH). Produced mainly in the&nbsp;</span><a href=\"https://www.niddk.nih.gov/Dictionary/P/pituitary-gland\" style=\"color:blue; text-decoration:underline\"><span style=\"color:black\">pituitary gland</span></a><span style=\"color:black\">, GH controls the physical growth of the body. In adults, too much of this hormone causes bones, cartilage, body organs, and other tissues to increase in size. Acromegaly is most often diagnosed in middle-aged adults, but symptoms can appear at any age. In children, too much growth hormone causes a condition called&nbsp;</span><a href=\"https://rarediseases.info.nih.gov/diseases/6506/gigantism\" style=\"color:blue; text-decoration:underline\"><span style=\"color:black\">gigantism</span></a><span style=\"color:black\"> rather than acromegaly.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Best screening test for acromegaly is serum insulin like growth factor-1 (IGF-1). </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Oral glucose challenge test with GH level:</span></strong><span style=\"font-size:12.0pt\"> While this test is used to diagnose acromegaly by demonstrating a lack of GH suppression after glucose administration, it is more complex and typically performed after IGF-1 screening suggests acromegaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Insulin-like growth factor 1 binding protein-3 (IGFBP-3):</span></strong><span style=\"font-size:12.0pt\"> Although IGFBP-3 levels are influenced by GH, they are not routinely used for screening acromegaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Random growth hormone levels:</span></strong><span style=\"font-size:12.0pt\"> These levels can fluctuate significantly throughout the day and are influenced by various factors, making random GH levels unreliable for diagnosing acromegaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum IGF-1 is the preferred initial test for screening acromegaly due to its reliability and the persistence of elevated levels in the presence of excessive GH production. This test provides a stable indicator of disease activity and is less variable than direct GH measurements.</span></span></span></p>",
      "correct_choice_id": 46544,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11428,
      "choices": [
        {
          "id": 45678,
          "text": "<p><span style=\"font-size:12.0pt;\">SIADH</span></p>"
        },
        {
          "id": 45679,
          "text": "<p><span style=\"font-size:12.0pt;\">Diuretic induced hyponatremia</span></p>"
        },
        {
          "id": 45680,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral salt wasting syndrome</span></p>"
        },
        {
          "id": 45681,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudohyponatremia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old smoker who is a known case of hypertension was on enalapril and hydrochlorothiazide. He had an episode of hemoptysis and on evaluation, he was found to have bronchogenic carcinoma with brain metastasis. His lab values were Na-124mg/dL, creatinine - 2.8mg%, blood sugar 112mg/dL, blood urea - 24mg/dL, serum osmolality 255mosm, urine osmolality - 110 mosm, 24-hour urinary sodium - 110 and BP - 150/90 mmHg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following is the most probable diagnosis of the low sodium values in him? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q7098483",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066724,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) SIADH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is the most probable diagnosis in this patient. The diagnostic criteria and the patient's clinical presentation support this conclusion:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture31.jpg\" alt=\"\" width=\"1000\" height=\"267\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additionally, lung cancer (specifically bronchogenic carcinoma) can often cause SIADH, either through ectopic production of antidiuretic hormone (ADH) or related paraneoplastic syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Diuretic induced hyponatremia:</strong> Incorrect because the pattern of serum and urine osmolality does not align solely with diuretic use; the high urine sodium and euvolemia are more indicative of SIADH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cerebral salt wasting syndrome:</strong> Incorrect as this condition typically presents with hypovolemia and low blood pressure due to significant sodium and fluid loss, which is not evident in this patient who maintains a normal blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pseudohyponatremia:</strong> Incorrect because the reduced serum osmolality directly indicates true hyponatremia, not a distortion caused by high levels of lipids or proteins in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">SIADH can be associated with malignancies like lung cancer, presenting with hyponatremia, low serum osmolality, and inappropriately concentrated urine despite the presence of low plasma osmolality. This clinical scenario should prompt consideration of SIADH, particularly in patients with known malignancies and typical lab findings.</span></p>",
      "correct_choice_id": 45678,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11455,
      "choices": [
        {
          "id": 45786,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Septic shock</span></span></span></span></p>"
        },
        {
          "id": 45787,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiogenic shock</span></span></span></span></p>"
        },
        {
          "id": 45788,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></span></span></p>"
        },
        {
          "id": 45789,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myxedema coma</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A middle-aged woman with a history of constipation, dry skin and menorrhagia presents to the ER with altered sensorium, non-pitting edema, hypothermia, bradycardia, and hypotension. What is the most likely diagnosis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q6766426",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066740,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Myxedema coma</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myxedema coma is part of myxedema crisis which can be considered as &ldquo;<strong><em>Decompensated Hypothyroidism&rdquo;,</em></strong><em> </em>where, organ dysfunctions occur compared to hypothyroidism (functioning is fairly preserved). </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothermia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypotension</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoventilation</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Altered Mental Status (including coma /Hypersomnolence)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyponatremia (Euvolemic similar to SIADH)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal insufficiency may co-exist. Hence, treated with IV steroids + IV levothyroxine/Nasogastric LT4. </span></span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroid given to prevent precipitation of adrenal crisis as well.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Often precipitated by infection or major cardiopulmonary or neurologic illness. Rarely precipitated by severe cold climate exposure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No obvious source, fever suggestive of septic shock given in the question.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No cardiac symptoms, elevated JVP, cardiac risk factors.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dry-skin, hypotension, hypothermia, menorrhagia as presentation of Hypoglycemia is unlikely.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases where a patient presents with hypothermia, bradycardia, hypotension, and altered mental status, especially in conjunction with a history suggestive of hypothyroidism, myxedema coma should be considered a critical diagnosis. Immediate and aggressive thyroid hormone replacement therapy is essential for survival.</span></span></span></span></p>",
      "correct_choice_id": 45789,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11484,
      "choices": [
        {
          "id": 45902,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in Systolic blood pressure 20 mmHg after 6 mins of standing</span></p>"
        },
        {
          "id": 45903,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in Diastolic blood pressure 20 mmHg after 6 mins of standing</span></p>"
        },
        {
          "id": 45904,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in Systolic blood pressure 20 mmHg after 3 min of standing</span></p>"
        },
        {
          "id": 45905,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in diastolic blood pressure 20 mmHg after 3 mins of standing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">True about the definition of Postural Hypotension: (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q7708891",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066760,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decrease in systolic blood pressure 20 mm Hg after 3 mins of standing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>“3-20-10”</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12pt;\">mnemonic can aid in remembering the definition of orthostatic hypotension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sustained fall of SBP &gt; 20mmHg /DBP &gt; 10mmHg after 3 mins of standing. Usually, it is accompanied by a rise in HR.&nbsp;<strong>Absence of increase in heart rate suggest neurogenic/autonomic dysfunction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cause of Orthostatic Hypotension:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Cardiac pump failure</span></li><li><span style=\"font-size:12.0pt;\">Hypovolemia</span></li><li><span style=\"font-size:12.0pt;\">Endocrinopathies: AI, Pheochromocytoma.</span></li><li><span style=\"font-size:12.0pt;\">Venous pooling</span></li><li><span style=\"font-size:12.0pt;\">Medications</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A and B:&nbsp;</strong>These options extend the timing to 6 minutes, which is not standard for the initial assessment of orthostatic hypotension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;</strong>Specifies a diastolic drop which should be 10 mmHg, not 20 mmHg, thus making it incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Postural hypotension, also known as orthostatic hypotension, is defined as a significant drop in blood pressure when a person stands up from a sitting or lying position. The correct definition, as per the consensus, includes a decrease in systolic blood pressure of 20 mmHg or a decrease in diastolic blood pressure of 10 mmHg within 3 minutes of standing. The answer C correctly reflects the component of this definition regarding the systolic blood pressure drop.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cardiology, chap 21/695</strong></span></p>",
      "correct_choice_id": 45904,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11452,
      "choices": [
        {
          "id": 45774,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic acidosis with respiratory compensation</span></span></span></span></p>"
        },
        {
          "id": 45775,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory acidosis with metabolic compensation</span></span></span></span></p>"
        },
        {
          "id": 45776,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory alkalosis with metabolic compensation</span></span></span></span></p>"
        },
        {
          "id": 45777,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic alkalosis with respiratory compensation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The arterial blood gas findings of a patient are pH = 7.32, pCO2 = 50, HCO3- = 29. What is the diagnosis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q4116510",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066738,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Respiratory acidosis with metabolic compensation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s arterial blood gas (ABG) results indicate:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pH = 7.12 (&lt;7.4 = acidemic/acidosis) &rarr; Metabolic vs respiratory (pCO2 &gt; 40= Respiratory drive is towards acidosis while metabolic [HCO3-] is towards alkalosis) &rarr; Respiratory acidosis with metabolic compensation (Every 10 &uarr; pCO2 = &uarr;4 HCO3- = Chronic).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These findings are characteristic of <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">respiratory acidosis with metabolic compensation</span></strong>. In respiratory acidosis, the body compensates by increasing renal reabsorption of bicarbonate to buffer the excess hydrogen ions resulting from elevated CO2 levels, which shifts the pH back towards normal. This compensation is a slower process and suggests a chronic respiratory condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases where ABG shows a low pH and high pCO2 with compensatory high bicarbonate, the diagnosis is typically respiratory acidosis with metabolic compensation. This is indicative of a chronic condition where the body adjusts bicarbonate levels to buffer the increased acidity due to CO2 retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Acid-Base Disturbances</span></span></strong></span></span></p>",
      "correct_choice_id": 45775,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11479,
      "choices": [
        {
          "id": 45882,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuromyelitis optica</span></p>"
        },
        {
          "id": 45883,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple sclerosis</span></p>"
        },
        {
          "id": 45884,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute combined degeneration of spinal cord</span></p>"
        },
        {
          "id": 45885,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurosyphilis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient has recurrent optic neuritis of both eyes with extensive transverse myelitis. Visual acuity in the right eye is 6/60 and visual acuity in the left eye 6/18. The patient showed a partial response to steroids. What is the likely diagnosis? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q9356563",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066755,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Neuromyelitis optica</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bilateral optic neuritis with extensive transverse myelitis and partial steroid response is suggestive of NMO-Spectrum disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>MS usually causes U/L optic neuritis.&nbsp;<strong>LETM&nbsp;</strong>(Longitudinally extensive transverse myelitis)&nbsp;<strong>not common in MS</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>SACD usually affects the posterior column. LETM, optic neuritis not a feature of B12 deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Neurosyphilis is usually associated with RAPD (U/L Optic neuritis). LETM not common.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>WINGERCHUK Criteria for NMO-SD</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture45.jpg\" alt=\"\" width=\"1000\" height=\"642\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture46.jpg\" alt=\"\" width=\"1000\" height=\"668\"></p>",
      "correct_choice_id": 45882,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11460,
      "choices": [
        {
          "id": 45806,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryoglobulinemic vasculitis</span></p>"
        },
        {
          "id": 45807,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyarteritis nodosa</span></p>"
        },
        {
          "id": 45808,
          "text": "<p><span style=\"font-size:12.0pt;\">EGPA</span></p>"
        },
        {
          "id": 45809,
          "text": "<p><span style=\"font-size:12.0pt;\">Giant cell arteritis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A triad of skin lesions, asymmetric mononeuritis multiplex and eosinophilia is seen in which of the following conditions? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2949063",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066745,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) EGPA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is characterized by a combination of <strong>asthma, eosinophilia, and vasculitis </strong>affecting multiple organ systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical triad of skin lesions (such as purpura or nodules), asymmetric mononeuritis multiplex (manifesting as numbness, pain, or muscle weakness typically in the limbs), and eosinophilia is highly suggestive of this condition. EGPA is a type of ANCA-associated vasculitis but differs from others in its prominent eosinophilic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cryoglobulinemic vasculitis:&nbsp;</strong>Typically associated with hepatitis C infection and features immune complexes in the blood that precipitate in the cold. It commonly presents with palpable purpura, joint pains, and kidney involvement but not typically with eosinophilia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Polyarteritis nodosa (PAN):&nbsp;</strong>A medium vessel vasculitis that may present with similar features including neuropathy and skin lesions but does not typically include eosinophilia as a prominent feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Giant cell arteritis (GCA):&nbsp;</strong>Primarily affects large vessels, particularly the temporal arteries, and presents with symptoms such as headache, jaw claudication, and potential blindness. It does not feature the triad of skin lesions, mononeuritis multiplex, and eosinophilia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">EGPA is a distinctive form of vasculitis marked by asthma, eosinophilia, and a systemic vasculitis involving skin and nerves among other systems. Its recognition is crucial due to the need for early and aggressive treatment to prevent significant morbidity and mortality.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture55.jpg\" alt=\"\" width=\"1000\" height=\"554\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Rheumatology/Vasculitis/Chap 363</strong></span></p>",
      "correct_choice_id": 45808,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11477,
      "choices": [
        {
          "id": 45874,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        },
        {
          "id": 45875,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation</span></p>"
        },
        {
          "id": 45876,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocal atrial tachycardia</span></p>"
        },
        {
          "id": 45877,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial tachycardia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 68-year-old male admitted to the ICU for acute exacerbation of COPD develops a sudden onset of palpitations. The following ECG changes are seen. What is the most likely diagnosis? (AIIMS MAY 2019)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm69.jpg\" alt=\"\" width=\"300\" height=\"138\"></span></p>",
      "unique_key": "Q7409445",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066754,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Multifocal atrial tachycardia&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture44.jpg\" alt=\"\" width=\"1000\" height=\"741\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>VT is usually regular and wide QRS tachycardia (QRS &gt; 120ms).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>P waves usually absent in AF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>Atrial tachycardia is regular narrow QRS tachycardia with fixed morphology of P wave.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">MAT is usually associated with lung disease and occurs secondary to underlying hypoxemia.</span></li><li><span style=\"font-size:12.0pt;\">Treatment is with <strong>CCB &gt; BB&nbsp;</strong>to slow the atrial, ventricular rate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cardioversion is ineffective and contraindicated in this rhythm.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multifocal Atrial Tachycardia is characterized by multiple ectopic atrial activities leading to variable P wave morphologies and an irregular rhythm, often associated with underlying chronic pulmonary conditions. Management focuses on treating the underlying condition and stabilizing the rate with appropriate medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/chap 250/7033</strong></span></p>",
      "correct_choice_id": 45876,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11468,
      "choices": [
        {
          "id": 45838,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased schistocytes</span></p>"
        },
        {
          "id": 45839,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased PT</span></p>"
        },
        {
          "id": 45840,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased fibrinogen</span></p>"
        },
        {
          "id": 45841,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased FDPs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is wrong about DIC? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4165526",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066748,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Increased fibrinogen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Disseminated Intravascular Coagulation (DIC) is a complex condition characterized by systemic activation of blood clotting, which results in the generation and deposition of fibrin, leading to microvascular thrombi in various organs and contributing to multiple organ dysfunction syndrome. As a part of this process, there is widespread consumption of clotting factors and platelets, which leads to a paradoxical increase in bleeding risk.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Increased fibrinogen&nbsp;</strong>is incorrect because in DIC, fibrinogen is typically decreased, not increased. This decrease is due to its consumption during the formation of fibrin clots throughout the body.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>30% of patients w/DIC may have schistocytes on PS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Consumption of clotting factors leads to ↑PT, aPTT. Presence of normal PT, aPTT w/schistocytes hints towards possibility of MAHA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>FDP are elevated due to activation of coagulation cascade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In DIC, one typically sees a constellation of laboratory findings including decreased fibrinogen, increased PT and aPTT, elevated FDPs, and the presence of schistocytes on peripheral blood smear. These changes reflect both the excessive activation of the coagulation cascade and the secondary activation of fibrinolytic pathways, leading to the consumption of clotting factors and secondary bleeding complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Hematology/Coagulation disorders</strong></span></p>",
      "correct_choice_id": 45840,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11645,
      "choices": [
        {
          "id": 46546,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle fatigue</span></p>"
        },
        {
          "id": 46547,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent deep tendon reflexes</span></p>"
        },
        {
          "id": 46548,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal pupillary reflex</span></p>"
        },
        {
          "id": 46549,
          "text": "<p><span style=\"font-size:12.0pt;\">Ptosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is not a feature of myasthenia gravis among the following? (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q6229356",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066782,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Absent deep tendon reflexes.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Myasthenia gravis is an autoimmune neuromuscular disorder characterized by weakness and fatiguability of skeletal muscles. There is decrease in number of available acetylcholine receptors at neuromuscular junction due to an antibody mediated autoimmune attack.</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Visual problems, including drooping eyelids (ptosis) and double vision (diplopia)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Muscle weakness and fatigue may vary rapidly in intensity over days or even hours and worsen as muscles are used (early fatigue)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Facial muscle involvement causing a mask-like appearance; a smile may appear more like a snarl</span></li><li><span style=\"color:black;font-size:12.0pt;\">Trouble swallowing or pronouncing words</span></li><li><span style=\"color:black;font-size:12.0pt;\">Weakness of the neck or limbs</span></li><li><span style=\"color:black;font-size:12.0pt;\">Weakness increases during repeated use or late in the day and may improve following rest or sleep.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Deep tendon reflexes preserved.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Muscle fatigue:</strong> This is a defining symptom of MG, characterized by increased muscle weakness with continued activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Normal pupillary reflex:</strong> MG primarily affects voluntary muscles and typically does not impact the autonomic functions, including pupillary reflexes which remain normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ptosis:</strong> Ptosis, or drooping eyelids, is one of the common features of MG due to muscle weakness affecting the muscles that control eyelid elevation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Deep tendon reflexes are preserved in myasthenia gravis despite significant muscle weakness and fatigability, distinguishing it from other neuromuscular disorders that might also lead to reflex abnormalities.</span></p>",
      "correct_choice_id": 46547,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11457,
      "choices": [
        {
          "id": 45794,
          "text": "<p><span style=\"font-size:12.0pt;\">Check blood sugar level</span></p>"
        },
        {
          "id": 45795,
          "text": "<p><span style=\"font-size:12.0pt;\">Give oral antihypertensive</span></p>"
        },
        {
          "id": 45796,
          "text": "<p><span style=\"font-size:12.0pt;\">IV mannitol</span></p>"
        },
        {
          "id": 45797,
          "text": "<p><span style=\"font-size:12.0pt;\">CT brain</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An elderly diabetic and hypertensive patient was carried to the emergency room in a comatose state. On examination, the blood pressure was 170/100 mmHg and pulse rate were &gt;100/min. Plantar reflex was bilateral extensor. What is the next step to do? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q1939263",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066742,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Check Blood sugar level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evaluation of Common reversible emergency causes are targeted in the ER. Altered mental status occurring acutely can be remembered with MIST.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 1.</strong> Rx &gt;&gt;&gt; Dx priority (↓ Glucose).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture52.jpg\" alt=\"\" width=\"1000\" height=\"389\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>HTN emergency is treated with I.V. antihypertensives.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>I.V. mannitol is used in the management of cerebral edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>CT brain to be done after ruling out life-threatening reversible common causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial management of any comatose patient, particularly those with diabetes, should include rapid assessment of blood glucose levels to rule out hypo- or hyperglycemia as a reversible cause of the coma. This immediate action can be life-saving and should precede other investigations and treatments.</span></p>",
      "correct_choice_id": 45794,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11637,
      "choices": [
        {
          "id": 46514,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypochromia</span></p>"
        },
        {
          "id": 46515,
          "text": "<p><span style=\"font-size:12.0pt;\">Anisocytosis</span></p>"
        },
        {
          "id": 46516,
          "text": "<p><span style=\"font-size:12.0pt;\">Poikilocytosis</span></p>"
        },
        {
          "id": 46517,
          "text": "<p><span style=\"font-size:12.0pt;\">Anisochromia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What does the Red Cell Distribution Width (RDW) measure?&nbsp; (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q8565852",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066779,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Anisocytosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Red Cell Distribution Width (RDW) is a measure of the variation in red blood cell (RBC) size. Anisocytosis, which is the variation in the sizes of RBCs, is directly assessed by RDW. A higher RDW indicates a greater variation in size. RDW is used clinically to help differentiate between types of anemia and to provide insight into the underlying mechanisms of anemia. Normal RDW values range from 11-14%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hypochromia:</strong> Refers to RBCs having less color than normal, indicative of less hemoglobin content per cell, not directly related to RDW.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Poikilocytosis:</strong> Indicates variation in the shape of RBCs, not their size, hence not directly assessed by RDW.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anisochromia:</strong> Refers to variation in hemoglobin content among RBCs, which is not measured by RDW.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">RDW measures the variability in size of red blood cells, which is indicative of anisocytosis. High RDW is associated with conditions like iron deficiency anemia and other types of anemia, where there is significant variation in RBC sizes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IDA vs Thalassemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IDA- rbcs are small (low MCV ) with high RDW</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalassemia- RBCs are small (low MCV )&nbsp; with normal RDW</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/screenshot-2024-09-10-144228.png\" alt=\"\" width=\"1000\" height=\"457\"></span></p>",
      "correct_choice_id": 46515,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11515,
      "choices": [
        {
          "id": 46026,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 46027,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptokinase</span></p>"
        },
        {
          "id": 46028,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 46029,
          "text": "<p><span style=\"font-size:12.0pt;\">Prasugrel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a patient with non-ST-elevation myocardial infarction (NSTEMI). All the following can be used for treatment except? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q4390074",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066780,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Streptokinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of NSTEMI, the focus is on antiplatelet and anticoagulant therapy rather than fibrinolytic agents like streptokinase. Streptokinase is specifically used in the treatment of ST-elevation myocardial infarction (STEMI) where there is a fibrin-rich thrombus completely occluding a coronary artery. NSTEMI, in contrast, involves a partial occlusion by a platelet-rich thrombus, and fibrinolytics are generally not recommended because they are less effective and could potentially increase the risk of bleeding without significant benefits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspirin:&nbsp;</strong>As a foundational antiplatelet agent, aspirin is used in both STEMI and NSTEMI to reduce platelet aggregation and further thrombus formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clopidogrel:&nbsp;</strong>This is another antiplatelet drug that is used in the management of both STEMI and NSTEMI as part of dual antiplatelet therapy (DAPT) along with aspirin to provide greater protection against thrombotic events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prasugrel:&nbsp;</strong>Similar to clopidogrel, prasugrel is used in acute coronary syndrome (ACS) management, including NSTEMI, especially when percutaneous coronary intervention (PCI) is planned, due to its potent antiplatelet effects. (Prasugrel is given peri-procedurally).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture40.jpg\" alt=\"\" width=\"1000\" height=\"697\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21e chap 118/3518</strong></span></p>",
      "correct_choice_id": 46027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11647,
      "choices": [
        {
          "id": 46554,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">To be done in lateral recumbent position</span></p>"
        },
        {
          "id": 46555,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Breath holding is not necessary</span></p>"
        },
        {
          "id": 46556,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The bevel should face upwards while inserting the needle.</span></p>"
        },
        {
          "id": 46557,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Coagulopathy is not a contraindication.</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Regarding the procedure done with the needle shown below, which of the following is false?</span><span style=\"font-size:12.0pt;\"> (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm108.jpg\" alt=\"\" width=\"400\" height=\"302\"></span></p>",
      "unique_key": "Q5641428",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066765,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Coagulopathy is not a contraindication.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image depicts a spinal needle used primarily for lumbar puncture (LP), a procedure where cerebrospinal fluid (CSF) is collected from the lumbar cistern. The procedure can be conducted in either the lateral recumbent position or sitting position, depending on the patient's comfort and the physician's preference. The bevel orientation during insertion affects the dural fibers; positioning it parallel (typically upwards) minimizes dural fiber tearing and the subsequent likelihood of post-lumbar puncture headaches. Importantly, coagulopathy is a significant contraindication for lumbar puncture due to the increased risk of spinal hematoma and severe complications associated with bleeding around the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. To be done in lateral recumbent position:</strong> This is true and is one of the standard positions for performing an LP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Breath holding is not necessary:</strong> During LP, patients are advised to breathe normally to avoid increases in intra-abdominal and intrathoracic pressure, which could affect CSF dynamics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The bevel should face upwards while inserting the needle:</strong> This is a recommended practice to reduce the risk of post-procedure complications, such as a post-dural puncture headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Coagulopathy is a contraindication for lumbar puncture due to the risk of bleeding and potential for serious complications, contrary to the incorrect statement provided. Always assess the patient’s coagulation status prior to performing an LP.</span></p>",
      "correct_choice_id": 46557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11414,
      "choices": [
        {
          "id": 45622,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Potassium</span></p>"
        },
        {
          "id": 45623,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Magnesium</span></p>"
        },
        {
          "id": 45624,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Sodium</span></p>"
        },
        {
          "id": 45625,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Calcium</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 36-year-old male came with complaints of ascending weakness in both lower limb and upper body. There was no history of trauma. Which of the following is the next investigation? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7137315",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066717,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Serum Potassium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Disturbance in serum potassium levels (hypokalemia or hyperkalemia) present with ascending muscle weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Serum Magnesium:</strong> Incorrect for this scenario as disturbances in magnesium typically cause tetany (muscle spasms) when low and generalized weakness when high, but are less directly linked to the type of ascending muscle weakness described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Serum Sodium:</strong> Incorrect because changes in serum sodium levels generally affect neurological function but do not typically cause muscular weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Serum Calcium:</strong> Incorrect as calcium imbalances would more likely cause tetany (from hypocalcemia) or symptoms like fatigue, depression, and cardiac arrhythmias (from hypercalcemia), rather than ascending muscle weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The disturbances in serum potassium levels can manifest as muscle weakness, making it a vital test in cases of unexplained, ascending muscle weakness without trauma.</span></p>",
      "correct_choice_id": 45622,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11402,
      "choices": [
        {
          "id": 45574,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hypersecreting adenoma</span></p>"
        },
        {
          "id": 45575,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Papillary carcinoma thyroid</span></p>"
        },
        {
          "id": 45576,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Grave’s disease</span></p>"
        },
        {
          "id": 45577,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Lateral aberrant thyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Below is a radioactive scan for thyroid pathology. which of the following is the most probable diagnosis: (AIIMS MAY 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm56.jpg\" alt=\"\" width=\"300\" height=\"256\"></span></p>",
      "unique_key": "Q3881893",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066713,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hypersecreting Adenoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image findings are suggestive of hypersecreting adenoma.</span></p><p>&nbsp;</p><ol><li><span style=\"color:black;font-size:12.0pt;\">Increased uptake in the right lobe at the thyroid</span></li><li><span style=\"color:black;font-size:12.0pt;\">Suppressed uptake in left lobe of thyroid</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These findings are highly suggestive of a hypersecreting adenoma. This condition occurs when a benign tumor in the thyroid gland produces thyroid hormone independently of the normal regulatory mechanisms, leading to an overactive area (hot spot) in one part of the thyroid, with suppression of activity in the rest of the gland due to negative feedback mechanisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Papillary carcinoma of the thyroid:</strong> Incorrect as this type of cancer typically presents with a \"cold nodule,\" which shows reduced or no uptake on a radioactive scan. The scan shows no areas of reduced uptake indicative of a cold nodule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Grave’s disease:</strong> Incorrect because Grave's disease generally causes a diffuse increase in uptake across the entire thyroid gland due to widespread stimulation of thyroid tissue. The scan does not show diffuse uptake, which rules out Grave's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lateral aberrant thyroid:</strong> Incorrect as this condition involves ectopic thyroid tissue that might appear as functioning thyroid tissue outside the normal location. The scan does not indicate any ectopic thyroid tissue.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypersecreting adenoma in the thyroid is characterized by increased radioactive uptake in one area of the thyroid with suppression in other areas, reflecting independent hormone production from the adenoma.</span></p>",
      "correct_choice_id": 45574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11632,
      "choices": [
        {
          "id": 46494,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium gluconate</span></p>"
        },
        {
          "id": 46495,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin drip</span></p>"
        },
        {
          "id": 46496,
          "text": "<p><span style=\"font-size:12.0pt;\">Salbutamol nebulisation</span></p>"
        },
        {
          "id": 46497,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulphate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Management of hyperkalemia includes all except : (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q7978434",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066720,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Magnesium sulphate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Magnesium sulfate</strong> is not typically used for the treatment of hyperkalemia. It is more commonly used in the management of eclampsia in pregnant women and for its neuromuscular blocking effects in various other medical conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The management of hyperkalemia typically involves interventions that stabilize the cardiac membrane, shift potassium into cells, and remove potassium from the body. Common treatments include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Calcium gluconate</strong>: Which stabilizes the cardiac membrane and does not lower potassium levels but protects the heart from the effects of hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Insulin drip</strong>: Often accompanied by glucose, which drives potassium back into cells, thereby lowering its serum concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp; C. Salbutamol nebulization</strong>: A beta-agonist that promotes the movement of potassium into cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management of hyperkalemia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Calcium gluconate- reduces plasma K+ concentration by redistribution in cells rapidly</span></li><li><span style=\"font-size:12.0pt;\">Insulin- lowers plasma K+ concentration by moving potassium intracellular, insulin dose used – 10units of IV regular insulin f/b 50ml of 50%dextrose</span></li><li><span style=\"font-size:12.0pt;\">Salbutamol</span></li><li><span style=\"font-size:12.0pt;\">Cation exchange resins, diuretics, dialysis.</span></li></ul>",
      "correct_choice_id": 46497,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11513,
      "choices": [
        {
          "id": 46018,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">20 mEq</span></span></span></span></p>"
        },
        {
          "id": 46019,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">400 mEq</span></span></span></span></p>"
        },
        {
          "id": 46020,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">200 mEq</span></span></span></span></p>"
        },
        {
          "id": 46021,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">720 mEq</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The serum electrolyte values of a patient weighing 60 kg are given below. Calculate the sodium deficit in the patient. pH: 7.42, Na+: 120 mEq/L, serum K+: 4 mEq/L, serum CI-: 90 mEq/L? (AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q4957999",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066747,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">720 mEq</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium Deficit</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> = Body weight x (0.6) x (desired sodium- actual sodium) [Note: 0.5 if female]= 60*0.6*(140-120) = 720 mEq.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Correction should not exceed 6-8 mEq/day in chronic hyponatremia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium deficit - </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rate of Correction</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It&#39;s critical to correct chronic hyponatremia slowly to avoid complications like osmotic demyelination syndrome. The recommended rate of correction should not exceed 6-8 mEq/L per day.</span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monitoring</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Frequent monitoring of serum sodium levels is necessary during the correction phase to adjust the treatment as needed and prevent overcorrection.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Harrison 21/Fluid and electrolyte/Chap 53</span></span></strong></span></span></p>",
      "correct_choice_id": 46021,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11493,
      "choices": [
        {
          "id": 45938,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab</span></p>"
        },
        {
          "id": 45939,
          "text": "<p><span style=\"font-size:12.0pt;\">Cladribine</span></p>"
        },
        {
          "id": 45940,
          "text": "<p><span style=\"font-size:12.0pt;\">Vemurafenib</span></p>"
        },
        {
          "id": 45941,
          "text": "<p><span style=\"font-size:12.0pt;\">Interferon-alpha</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is the drug of choice for hairy cell leukemia? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q2807257",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066763,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Cladribine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is a purine analogue used in the treatment of Hairy cell leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cladribine-phosphates&nbsp;<strong>interfere with DNA synthesis&nbsp;</strong>and repair through incorporation into DNA and through <strong>inhibition of enzymes involved in DNA metabolism</strong>, including DNA polymerase and ribonucleotide reductase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A&nbsp;&amp;&nbsp;D&nbsp;</strong>are not used in Hairy cell leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Hairy cell leukemia patients have mutation in BRAF pathway and hence, <strong>Vemurafenib (BRAF inhibitor) is used as second line agent in refractory cases</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cladribine remains the first-line treatment for hairy cell leukemia due to its high efficacy in inducing remissions.</span></p>",
      "correct_choice_id": 45939,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11420,
      "choices": [
        {
          "id": 45646,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">1<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 45647,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">2<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 45648,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">3<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 45649,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">4<sup>1/2 </sup>hours</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">What is the window period for thrombolysis in case of stroke? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q1187614",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066721,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 4<sup>1/2</sup> hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The window period for the administration of intravenous recombinant tissue plasminogen activator (rtPA) in the case of an acute ischemic stroke is 4½ hours from the onset of symptoms. This time frame is critical as rtPA is most effective when administered early, aiming to dissolve the blood clot and restore blood flow to the affected part of the brain, thus minimizing or reversing the damage caused by the stroke.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Indications:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">After Clinical diagnosis of stroke established</span></li><li><span style=\"color:black;font-size:12.0pt;\">If onset of symptoms to time of drug administration &lt;/= 4.5 hours</span></li><li><span style=\"color:black;font-size:12.0pt;\">If age &gt;/= 18 years</span></li><li><span style=\"color:black;font-size:12.0pt;\">CT scan showing no hemorrhage or edema of &gt;1/3<sup>rd</sup> of the MCA territory</span></li><li><span style=\"color:black;font-size:12.0pt;\">Consent given by patient or surrogate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Contraindications:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Coma/stupor/ recent MI.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Major surgery in last 14 days/ GI bleeding in last 21 days/ minor stroke symptoms.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Rapidly improving symptoms.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Sustained BP &gt; 185/110 mmHg despite treatment.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Platelets &lt; 100,000; HCT &lt; 25%; glucose &lt; 50 or &gt; 400 mg/dL.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Use of heparin within 48hrs and prolonged PTT or elevated INR.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Prior stroke or head injury within 3 months; prior intracranial hemorrhage.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The therapeutic window for thrombolysis in acute ischemic stroke using rtPA is up to 4½ hours from symptom onset, and strict criteria must be met to ensure the safety and efficacy of treatment. This timeframe is crucial for maximizing the potential benefits of the treatment while minimizing risks.</span></p>",
      "correct_choice_id": 45649,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11404,
      "choices": [
        {
          "id": 45582,
          "text": "<p style=\"margin-left:3px;\"><span style=\"color:black;font-size:12.0pt;\">Paralysis agitans</span></p>"
        },
        {
          "id": 45583,
          "text": "<p style=\"margin-left:3px;\"><span style=\"color:black;font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 45584,
          "text": "<p style=\"margin-left:3px;\"><span style=\"color:black;font-size:12.0pt;\">Alzheimer’s disease</span></p>"
        },
        {
          "id": 45585,
          "text": "<p style=\"margin-left:3px;\"><span style=\"color:black;font-size:12.0pt;\">Huntington chorea</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Which of the following disease pathogenesis primarily involves the marked structure: (AIIMS MAY 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm57.jpg\" alt=\"\" width=\"300\" height=\"188\"></span></p>",
      "unique_key": "Q3064147",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066714,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Paralysis agitans</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>substantia nigra is the marked structure in the transverse section</strong> of the brain that is shown. Degeneration of the substantia nigra is observed in Parkinson's disease, commonly referred to as paralysis agitans.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Due to the <strong>presence of neuromelanin granules</strong>, which aid in the manufacture of dopamine, <strong>the substantia nigra is pigmented</strong>. The substantia nigra lacks or has less pigmentation in Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parkinson's disease is characterized by bradykinesia, stiffness, and resting tremors. It's also known as paralysis agitans due to the motor dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Depression:</strong> Incorrect because depression is typically associated with dysfunctions in other brain regions such as the prefrontal cortex and limbic system, not specifically the substantia nigra.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Alzheimer’s disease:</strong> Incorrect as Alzheimer's disease primarily involves the cerebral cortex and hippocampus, leading to amyloid plaques and neurofibrillary tangles, rather than specific damage to the substantia nigra.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Huntington chorea:</strong> Incorrect because Huntington’s disease involves degeneration of the striatum and other parts of the brain but does not primarily affect the substantia nigra.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The substantia nigra's degeneration is central to the pathogenesis of Parkinson's disease, manifesting as motor symptoms like bradykinesia, stiffness, and resting tremors.</span></p>",
      "correct_choice_id": 45582,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74915,
      "choices": [
        {
          "id": 298557,
          "text": "<p><span style=\"font-size:16px;\">Lobar infiltrates – Pyogenic pneumonia</span></p>"
        },
        {
          "id": 298558,
          "text": "<p><span style=\"font-size:16px;\">Hilar infiltrates – Malignancy</span></p>"
        },
        {
          "id": 298559,
          "text": "<p><span style=\"font-size:16px;\">Interstitial infiltrates – Mycoplasma</span></p>"
        },
        {
          "id": 298560,
          "text": "<p><span style=\"font-size:16px;\">Aspiration pneumonia – Upper segment of right lower lobe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 46-year-old diabetic presented with fever, malaise, and cough. His chest X-ray is shown. Which of the following is correct? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8xKbZoP.png\" width=\"334\" height=\"412\"></span></p>",
      "unique_key": "Q9071156",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066725,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Interstitial infiltrates – Mycoplasma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The chest X-ray shows <strong>bilateral patchy infiltrates</strong>, particularly in the lower lobes. This pattern is characteristic of <strong>atypical pneumonia</strong>, specifically <strong>Mycoplasma pneumonia</strong>. In Mycoplasma infections, infiltrates tend to be <strong>interstitial and patchy</strong>, not dense consolidation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Lobar infiltrates – Pyogenic pneumonia:</strong> Incorrect. Pyogenic pneumonia typically shows dense consolidation with air bronchograms in a lobar distribution</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Hilar infiltrates – Malignancy:&nbsp;</strong>Incorrect. Hilar regions appear normal. Malignancy typically presents with hilar masses or lymphadenopathy</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Aspiration pneumonia – Upper segment of right lower lobe:</strong> Incorrect. Although aspiration pneumonia often affects this segment, this patient shows no risk factors for aspiration and has <strong>bilateral</strong> infiltrates</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Bilateral patchy interstitial infiltrates</strong> on chest X-ray, along with fever, malaise, and cough, are characteristic of <strong>atypical pneumonia</strong>, particularly <strong>Mycoplasma pneumonia</strong>.</span></p>",
      "correct_choice_id": 298559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}